# MeMed

> The Immune System is Built to Communicate. Our Mission is to Listen.

> Generated by All in One SEO Pro v5.0.4, this is an llms.txt file, used by LLMs to index the site.

## Sitemaps

- [XML Sitemap](https://memed-staging.freshy.dev/sitemap.xml): Contains all public & indexable URLs for this website.

## Blog Posts

- [Data on the utility of MeMed BV to be presented at ACEP25](https://www.captodayonline.com/data-on-the-utility-of-memed-bv-to-be-presented-at-acep25/)
- [New Sepsis Testing Tools Emerging While Adoption Drags Amid Clinical Utility Concerns](https://www.360dx.com/infectious-disease/new-sepsis-testing-tools-emerging-while-adoption-drags-amid-clinical-utility)
- [More than 100,000 patients tested with MeMed BV](https://www.captodayonline.com/more-than-100000-patients-tested-with-memed-bv/)
- [MeMed’s Diagnostics, BV Test and Key Platform Get 510(k) Clearance](https://www.wcgclinical.com/fdanews/#new_tab)
- [MeMed Receives CE Mark for Diagnostic Platform & Infection Assay](https://www.wcgclinical.com/fdanews/#new_tab)
- [Smiles or Standards? How Satisfaction Surveys Influence ED Decisions](https://memed-staging.freshy.dev/smiles-or-standards-how-satisfaction-surveys-influence-ed-decisions/): A few months ago, I found myself in the Emergency Department (ED) after my little boy had a minor injury. We waited a while, but when care finally came, it was professional and effective. Just as we were about to leave, a nurse handed me a patient satisfaction survey. It felt routine—another piece of paperwork.
- [MeMed: Beat Müller, Dave Hickey, David Shulkin](https://www.360dx.com/people-news/memed-beat-muller-dave-hickey-david-shulkin/98496)
- [FDA Grants Breakthrough Designation Status for Test for Patients with Suspected Sepsis](https://www.contagionlive.com/view/fda-grants-breakthrough-designation-status-for-test-for-patients-with-suspected-sepsis)
- [A New Blood Test Could Stop Doctors From Overprescribing Antibiotics](https://time.com/3750414/antibiotics-overprescribe-bacterial-viral-infections-immunoxper/#new_tab)
- [MeMed BV Test Demonstrates Antibiotic Overuse Reduction in First US Interventional Trial](https://firstwordpharma.com/story/5899927#new_tab)
- [Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief](https://www.bioworld.com/articles/712647-other-news-to-note-for-september-30-2024?v=preview#new_tab)
- [Trial shows MeMed BV reduces use of unnecessary antibiotics](https://www.captodayonline.com/trial-shows-memed-bv-reduces-use-of-unnecessary-antibiotics/#new_tab)
- [Determining If the Patient’s Infection is Bacterial or Viral](https://www.contagionlive.com/view/determining-if-the-patient-s-infection-is-bacterial-or-viral#new_tab)
- [Know Thy Enemy: MeMed’s Diagnostic Reduces Antibiotic Overuse in U.S. Trial](https://www.insideprecisionmedicine.com/topics/precision-medicine/know-thy-enemy-memeds-diagnostic-reduces-antibiotic-overuse-in-u-s-trial/#new_tab)
- [Maccabi Healthcare Services Announces it is the First HMO in the World to Include...](https://www.globenewswire.com/en/news-release/2022/06/07/2457291/0/en/Maccabi-Healthcare-Services-announces-it-is-the-first-HMO-in-the-world-to-include-MeMed-BV-test-as-part-of-routine-care.html#new_tab)
- [DiaSorin receives FDA 510(K) clearance for Its LIAISON MeMed BV test](https://www.360dx.com/regulatory-news-fda-approvals/diasorin-gets-fda-clearance-test-differentiate-bacterial-viral#.YvbM5nYpBD8#new_tab)
- [MeMed raises $93M to accelerate commercialization of its host immune-response...](https://finance.yahoo.com/news/memed-raises-93m-accelerate-commercialization-070000729.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cubWUtbWVkLmNvbS8&guce_referrer_sig=AQAAANOYQHv0c5t1WlHHvQrLWShevIy0ztt7776xS6n2D-c99jKRl1CamDVadf3W06NZ7u-krxTkgUEAPiwAlhyyeIMWlEJ7mQzPvv0Ul-9412ZuJCJcX790gDuVhGCTrEXpNT-RQ182ewYPfPma3xywDND49jVoWRaRQ8MNAiKUK-Ps#new_tab)
- [Maimonides Medical Center adopts revolutionary technology that quickly..](https://apnews.com/press-release/globe-newswire/technology-health-new-york-brooklyn-medical-technology-47b3ad395aaf894ac4ad7a7439733aea#new_tab)
- [After a decade and 130 million dollars, the MeMed test receives FDA clearance](https://www.themarker.com/technation/2021-09-20/ty-article/.premium/0000017f-ef24-dc28-a17f-ff37a62d0000#new_tab)
- [2021 Dun & Bradstreet’s Best Companies to Work For](https://www.duns100.co.il/en/rating/High_Tech/Best_Start_Up_Companies_to_work_for_Up_To_100_Employees/2021#new_tab)
- [Platform distinguishing between viral and bacterial infections cleared by FDA...](https://www.med-technews.com/news/Medtech-Regulatory-News/platform-distinguishing-between-bacterial-and-viral-infectio/#new_tab)
- [FDA Clears New Technology to Differentiate Bacterial, Viral Infections Using Biomarkers](https://www.idse.net/FDA-Approvals/Article/09-21/FDA-Clears-New-Technology-to-Differentiate-Bacterial-Viral-Infections-Using-Biomarkers/64746#new_tab)
- [Bacterial and Viral Biomarker Test Gains US FDA Clearance](https://www.duns100.co.il/en/rating/High_Tech/Best_Start_Up_Companies_to_work_for_Up_To_100_Employees/2021#new_tab)
- [MeMed Gets FDA 510(k) Clearance for Test Distinguishing Between...](https://www.360dx.com/infectious-disease/memed-gets-fda-510k-clearance-test-distinguishing-between-viral-bacterial#.YVW-dZpByUl#new_tab)
- [Israel’s MeMed gets FDA approval for ‘breakthrough’ infection test](https://www.timesofisrael.com/israels-memed-gets-fda-approval-for-breakthrough-infection-test/#new_tab)
- [MeMed Received FDA Clearance for Infection Test](https://nocamels.com/2021/09/memed-diagnostics-medical-fda-clearance/#new_tab)
- [FDA clears MeMed’s point-of-need infectious disease test](https://www.bioworld.com/articles/511586-fda-clears-memeds-point-of-care-infectious-disease-test?v=preview#new_tab)
- [US approves MeMed test to distinguish bacterial from viral infections](https://www.medicaldevice-network.com/news/memed-bacteria-virus-test/#new_tab)
- [Rapid test to distinguish bacterial and viral infections wins US approval](https://www.ft.com/content/20f1671a-3cdb-41f5-9498-d6fb2a7f92a4#new_tab)
- [Pioneering test which can indicate COVID-19 severity receives CE Mark](https://www.dailymail.co.uk/news/article-9830429/Pioneering-15-minute-Covid-test-approved-sale-UK-hospitals.html#new_tab)
- [COVID-19 severity test is approved for sale in the UK](https://www.telegraph.co.uk/business/2021/07/27/covid-severity-test-approved-sale-uk/#new_tab)
- [Longitude Prize: Bacterial or Viral: To Treat or Not to Treat with Antibiotics](https://longitudeprize.org/blog/bacterial-or-viral-to-treat-or-not-to-treat-with-antibiotics/#new_tab)
- [Test predicting COVID-19 severity receives CE mark](https://www.med-technews.com/news/Medtech-Diagnostics-news/test-predicting-severe-covid-19-outcomes-receives-ce-mark/#new_tab)
- [MeMed’s Covid-19 severity test receives its CE Mark to predict severe outcomes](https://www.calcalistech.com/ctech/articles/0,7340,L-3913362,00.html#new_tab)
- [MeMed Wins $4.1M DOD Grant toward Manufacturing of POC Platform](https://www.insideprecisionmedicine.com/topics/translational-research/bacterial-diseases/memed-wins-4-1m-dod-grant-toward-manufacturing-of-poc-platform/#new_tab)
- [MeMed’s co-founder and CEO, Dr. Eran Eden on the BioBoss Podcast](https://bioboss.buzzsprout.com/236855/5433820-26-eran-eden-co-founder-and-ceo-of-memed#new_tab)
- [Israeli firm advances diagnostic solutions for Covid-19](https://www.israel21c.org/israeli-firm-advances-diagnostic-solutions-for-covid-19/#new_tab)
- [Interview with Eran Eden, MeMed’s CEO](https://www.youtube.com/watch?v=LrnsxHQIQxA&t=81s#new_tab)
- [Israeli Startups Join The Fight Against Coronavirus](https://www.forbes.com/sites/gilpress/2020/03/18/israeli-startups-join-the-fight-against-coronavirus/?sh=2a32c77e4d0e#new_tab)
- [OurCrowd Portfolio Companies Pivot to Tackle Coronavirus Pandemic](https://www.crowdfundinsider.com/2020/03/158955-ourcrowd-portfolio-companies-pivot-to-tackle-coronavirus-pandemic/#new_tab)
- [Technology Pioneers 2019](https://widgets.weforum.org/techpioneers-2019/companies/memed-diagnostics/index.html#new_tab)
- [Rapid blood test to ‘cut antibiotic use’](https://www.bbc.com/news/health-31941538#new_tab)
- [The Chronic Illness Puzzle: Microbiomes, Inflammation, and the Modern World](https://memed-staging.freshy.dev/a-tale-from-amrs-past-beyond-penicillin-a-century-of-medical-marvels-and-neglected-microbial-battlefields-2/): Is human health in decline? A puzzling question in a time of technological innovation and revolutionary medicine. We are starting to harness the power of CRISPR-cas biology, gene-editing to correct our genetic errors & flaws. New ‘blockbuster’ drugs have come to market that help induce weight loss and can help manage obesity. Plus, we can’t
- [The Invisible Threat: Uncovering an Unintended Antibiotic in Our Midst](https://memed-staging.freshy.dev/the-invisible-threat-uncovering-an-unintended-antibiotic-in-our-midst/): Antimicrobial resistance is a one health problem requiring action on multiple fronts. It’s not just about reducing antibiotics in a clinical setting, other sectors and every individual or potential antibiotic consumer needs to chip in. However, a smart way to create immediate gains could be that we target the most commonly used antibiotic in the
- [A Tale From AMR’s Past: Beyond Penicillin -  A Century of Medical Marvels and Neglected Microbial Battlefields](https://memed-staging.freshy.dev/a-tale-from-amrs-past-beyond-penicillin-a-century-of-medical-marvels-and-neglected-microbial-battlefields/): In 4 years, the field of medicine will celebrate the 100th birthday of an important discovery. It fueled a century of medical marvel and innovation in medicine: Penicillin! The first of many antibiotics discovered by humans. But… will we have reason for celebration in 2028? Penicillin still saves countless lives today but the magnificence of
- [Oops! Medical Errors and the Quest for Quality Care](https://memed-staging.freshy.dev/oops-medical-errors-and-the-quest-for-quality-care/): Almost daily we witness groundbreaking technologies and outstanding medical advancements that save patients’ lives. But from time to time, if you keep scrolling to the bottom of your feed, you might find a less positive article on medical errors… From the misinterpretation of symptoms in ancient times to the infamous case of wrong-site surgery in
- [Tiny Patients, Big Decisions: The Delicate Balance of Antibiotics in Pediatric Care](https://memed-staging.freshy.dev/2024-jan-15-tiny-patients-big-decisions-the-delicate-balance-of-antibiotics-in-pediatric-care-2/): I remember the night I brought my little boy into the urgent care. Same symptoms as always: fever, runny nose and persistent cough, but for me, the world narrowed down to a single thought. "I want whatever will make my son feel better, fast." This sentiment, borne out of love and concern, often shadows the
- [MeMed BV can help fight AMR!](https://memed-staging.freshy.dev/memed-bv-can-help-fight-amr/): Accurately distinguishing between bacterial and viral infections, promoting appropriate antibiotic use and reducing unnecessary prescriptions. Link to BV Product Page (6) (7) (8)
- [A Three Decade Decline in New Antibiotic Development](https://memed-staging.freshy.dev/a-three-decade-decline-in-new-antibiotic-development/): The number of new antibiotics developed and approved has decreased steadily over the past three decades, leaving fewer options to treat resistant bacteria.(5)
- [Antibiotic Misuse is the main driver in the development of drug-resistance pathogens](https://memed-staging.freshy.dev/antibiotic-misuse-is-the-main-driver-in-the-development-of-drug-resistance-pathogens/): Approximately 30%-50% of antibiotics prescriptions are unnecessary in U.S doctor's offices and ED(4).
- [Antimicrobial Resistance (AMR) occurs when bacteria no longer respond to antimicrobial medicines](https://memed-staging.freshy.dev/antimicrobial-resistance-amr-occurs-when-bacteria-no-longer-respond-to-antimicrobial-medicines/): As a result of drug resistance, antibiotics become ineffective and infections become difficult or impossible to treat, increasing the risk of disease spread, severe illness, disability and death.
- [Five Key Learnings From Asking the "Is it Bacterial or Viral?" Question](https://memed-staging.freshy.dev/2024-feb-11-5-key-learnings-bacterial-viral-question/): All of us become sick every now and then, whether we like or not. In today’s world, you don’t have to be an infectious disease specialist or microbiologist to know that what makes us sick are small microbes that we call viruses and bacteria. Although the answer is thus straightforward, the question ‘Is it bacterial
- [Tiny Patients, Big Decisions: The Delicate Balance of Antibiotics in Pediatric Care](https://memed-staging.freshy.dev/2024-jan-15-tiny-patients-big-decisions-the-delicate-balance-of-antibiotics-in-pediatric-care/): I remember the night I brought my little boy into the urgent care. Same symptoms as always: fever, runny nose and persistent cough, but for me, the world narrowed down to a single thought. "I want whatever will make my son feel better, fast." This sentiment, borne out of love and concern, often shadows the
- [Glyphosate and Human Health: Navigating the Maze of Uncertainty](https://memed-staging.freshy.dev/glyphosate-and-human-health-navigating-the-maze-of-uncertainty/): Does glyphosate impact human health? This is where we stopped our previous conversation. It’s the question that has been on my mind since I first learned that glyphosate is an antibiotic. It’s the question for which I still don’t have a proper answer. It’s a question that has provided me with many thoughts and additional

## Pages

- [Home](https://memed-staging.freshy.dev/): MeMed BV Delivers a Breakthrough in Rapid Diagnostics Our 15-minute test differentiates between bacterial and viral infections, empowering patients, optimizing provider workflows, and strengthening public health. MeMed BV® delivers a breakthrough in rapid diagnostics Our 15-minute test differentiates between bacterial and viral infections, empowering patients, optimizing provider workflows, and strengthening public health. Request Demo Minimizing
- [Learning Center - new](https://memed-staging.freshy.dev/learning-center-new/)
- [Nurses Campaign New](https://memed-staging.freshy.dev/nurses/): Nurses Are the Heart and Soul of Emergency Care You know the nonstop rhythm of the ED- you keep patients moving, needs anticipated, and care delivered fast. But you also know how uncertainty, especially with infections, can bring it all to a halt. MeMed BV® is Here to Help With a simple blood test, it
- [Thank you - Nurses](https://memed-staging.freshy.dev/thank-you-nurses/): Thank you for your inquiry! Your submission has been sent and a representative will follow up with you shortly. Check out more from MeMed below: Products Learning Center
- [LP Template](https://memed-staging.freshy.dev/lp-template/): Webinar Title Line Goes Here Israel Israeli Date 01.01.2025 Time 19:30 Duration 1 Hour Event description Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and Learn More Event description
- [LP - Example](https://memed-staging.freshy.dev/lp-example/): Webinar Title Line Goes Here Israel Israeli Date 01.01.2025 Time 19:30 Duration 1 Hour Event description Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and Learn More Event description
- [Thank You Support](https://memed-staging.freshy.dev/thank-you-support/): Thanks for submitting this form! We will review your information shortly. Products Learning Center
- [Careers](https://memed-staging.freshy.dev/careers/): Explore innovative career opportunities at MeMed, where we are transforming diagnostics with rapid diagnostic tools. Join our mission to improve global health outcomes.
- [Thank You](https://memed-staging.freshy.dev/adoption-guide/thank-you/): Thank you for requesting the Adoption Guide. Your download will begin automatically. href=”https://memed-staging.freshy.dev/wp-content/uploads/MeMed-BV-Adoption-Guide-for-Clinical-Use-DOC00068-Rev-1-.pdf” download hidden
- [LEGAL: US Terms & Conditions of Sale (New)](https://memed-staging.freshy.dev/us-terms-and-conditions-of-sale/): This is the new exerpt
- [LEGAL: EU Terms & Conditions of Sale](https://memed-staging.freshy.dev/eu-terms-and-conditions-of-sale/): This is the new exerpt
- [FAQ](https://memed-staging.freshy.dev/faq/): Get answers to frequently asked questions about MeMed's diagnostic test as the MeMed BV® and the MeMed Key® platform. Find availability, and how our technology works to help you.
- [MeMed Clinical Case Competition Protocol](https://memed-staging.freshy.dev/memed-clinical-case-competition-protocol/): MeMed Clinical Case Competition Protocol Objective The MeMed Clinical Case Competition is designed for educational purposes only and not as an incentive to increase utilization of MeMed products. Participation is not intended to influence clinical decision-making and should not impact a participant’s independent medical judgment. Rather, it is meant to promote shared clinical learning through
- [Memed Event](https://memed-staging.freshy.dev/memed-event/): Your unique opportunityto grow your business with MeMed BV 11.09.25 Hungary Registration Form Registration Form Please enter contact person name Please enter company name Please enter a valid email address Please enter your location Please enter a valid website URL Please enter your team size Experience with Deploying Innovative Solutions Yes No Please select an
- [Thank You](https://memed-staging.freshy.dev/ga-aware-healthcare-providers/thank-you/): Thank you for your submission! We will review your application and if relevant our team will reach out to you Products Learning Center
- [Antimicrobial Resistance Page](https://memed-staging.freshy.dev/amr/): Antimicrobial Resistance (AMR) Occurs When Bacteria No Longer Responds To Antimicrobial Medicines As a result of antimicrobial resistance, antibiotics become ineffective and infections become difficult or impossible to treat, increasing the risk of disease spread, severe illness, disability and death1 AMR is one of the top global public health threats Global Deaths 0 M in
- [LEGAL: Virtual Patent Marking](https://memed-staging.freshy.dev/products-patent-marking/): Virtual Patent Marking This page is provided to satisfy the virtual patent marking provisions of the America Invents Act and provide notice under 35 U.S.C. § 287(a). The following products are protected by patents in the U.S. and elsewhere. The listing of patents below may not be all inclusive. The products listed below may be
- [LANDING PAGE: UCA storm simulator](https://memed-staging.freshy.dev/uca-storm-2025/): Bacterial or Viral? You Decide! Simulate urgent care scenarios. Order tests. Treat patients. See how your choices measure up. "*" indicates required fields Comments This field is for validation purposes and should be left unchanged. First name* Last name* Email* Job Title* Company State (Choose an Option)* State (Choose an Option)*AlabamaAlaskaAmerican SamoaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew
- [MeMed BV](https://memed-staging.freshy.dev/memed-bv/): MeMed BV® analyzes host immune response to distinguish between bacterial and viral infections in 15 minutes—helping clinicians make fast, informed decisions.
- [LANDING PAGE: UCA STORM NEW](https://memed-staging.freshy.dev/uca25/): Bacterial or Viral? You Decide! Simulate urgent care scenarios. Order tests. Treat patients. See how your choices measure up. "*" indicates required fields LinkedIn This field is for validation purposes and should be left unchanged. First name* Last name* Email* Job Title* Company State (Choose an Option)* State (Choose an Option)*AlabamaAlaskaAmerican SamoaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew
- [Pipeline](https://memed-staging.freshy.dev/pipeline/): Explore our pipeline of upcoming diagnostic products, including MeMed Universal Severity™. Stay ahead with our innovative developments in personalized diagnostics.
- [Home](https://memed-staging.freshy.dev/home-test-slider/): Discover innovative diagnostic solutions and how host-immune response is used for clinical decision making. Revolutionizing medical diagnostics.
- [Landing Page: Adoption Guide Form](https://memed-staging.freshy.dev/adoption-guide/): Access the MeMed Adoption Guide for step-by-step support in integrating our diagnostic platform. Learn how to streamline implementation and empower your care team.
- [MeMed Severity](https://memed-staging.freshy.dev/memed-severity/): MeMed Severity™ supports early risk assessment for severe outcomes in suspected infection or sepsis cases, helping improve care pathways and outcomes.
- [Case Examples](https://memed-staging.freshy.dev/learning-center/case-examples/): Case Examples MeMed BV was validated in independent, double-blinded, multi-national clinical studies with 30 publications and over 20,000 patients. Below you can find examples of real-world cases, anonymized and simplified into short, animated videos showing the value of BV in different clinical scenarios: Patients > 0 Medical Centers > 0 Countries 0 Case Examples Videos Case
- [Contact](https://memed-staging.freshy.dev/contact/): Contact MeMed for inquiries about our immunoassay diagnostic platforms, MeMed Key® and MeMed BV®. Connect with us to learn how we can support your medical needs.
- [Partners](https://memed-staging.freshy.dev/partners/): Flexible, fast, and clinically validated—MeMed BV® on Diasorin’s LIAISON platforms helps providers distinguish bacterial vs. viral infections with confidence.
- [LANDING PAGE: UK Campaign Video 2](https://memed-staging.freshy.dev/memed-economic-summary-2/): Exclusive Insights: MeMed BV Can Potentially Save Costs & Improve CAP Management Get a concise breakdown of this UK health economic study conducted by the York Health Economics Consortium (YHEC), evaluating the financial impact of MeMed BV on CAP patients in emergency departments. This video highlights the study methodology, results and key drivers for potential
- [LANDING PAGE: UK Campaign One pager Form](https://memed-staging.freshy.dev/memed-economic-summary/): Exclusive Insights: MeMed BV Can Potentially Save Costs & Improve CAP Management Get a concise breakdown of this UK health economic study conducted by the York Health Economics Consortium (YHEC), evaluating the financial impact of MeMed BV on CAP patients in emergency departments. This quick-to-read summary highlights the study methodology, results and key drivers for
- [LANDING PAGE: Pocket Card Form](https://memed-staging.freshy.dev/pocket-card/): MeMed BV® Pocket Card Learn more about the MeMed BV test with our easy-to-understand pocket card. Download now to navigate results with confidence and ease! "*" indicates required fields X/Twitter This field is for validation purposes and should be left unchanged. Looking for a quick guide to the MeMed BV score? First name* Last
- [MeMed Key](https://memed-staging.freshy.dev/memed-key/): Discover MeMed Key®, a revolutionary diagnostic platform that leverages immunodiagnostics to distinguish between bacterial and viral infections rapidly.
- [Landing Page: MeMed at AACC 2023 Form](https://memed-staging.freshy.dev/https-meeting-myadlm-org/): Symposium | July 25, 2023 | Anaheim, CA Real World Performance of MeMed BV: A Host-Response Test for Differentiating between Bacterial and Viral Infection in Adults and Pediatrics This presentation is organized into distinct chapters to facilitate easy navigation and viewing. David M. Engman, MD, PhD, Cedars Sinai Medical Center Sridevi Devaraj, PhD,
- [Compliance](https://memed-staging.freshy.dev/compliance-report/): Contact MeMed for inquiries about our immunoassay diagnostic platforms, MeMed Key® and MeMed BV®. Connect with us to learn how we can support your medical needs.
- [Request a Demo](https://memed-staging.freshy.dev/request-a-demo/): Request a demo of MeMed's advanced diagnostic tools, MeMed BV® and MeMed Key®. Learn firsthand how our rapid test products can enhance your medical practice.
- [Hospitalist V1](https://memed-staging.freshy.dev/hospitalist-2/): MeMed BV®Aiding Hospitalists with Clinical Decision-Making MeMed BV provides rapid and accurate differentiation between bacterial and viral infections, aiding hospitalists in making quick and confident admission and discharge decisions for patients with suspected acute infection. Suspected Acute Infections: A Hospitalist’s Complex Puzzle Admitting the right patients can be complex and challenging¹ Clinical uncertainty is often
- [Sepsis](https://memed-staging.freshy.dev/sepsis-2/): Sepsis: a global healthcare problem Sepsis is a significant global health issue, contributing to 20% of all global deaths² and poses a substantial economic impact on the entire health system³ 0 % Of all global deaths arerelated to sepsis¹ $ 0 Per patient when sepsis is detected at admission $ 0 For late detection of
- [Our Team](https://memed-staging.freshy.dev/our-team/): Meet the experts behind MeMed, a team dedicated to advancing diagnostic technologies through host response technologies. Learn more about our vision.
- [test](https://memed-staging.freshy.dev/test-3/): Request a Demo Bacterial Vs Infection "*" indicates required fields Company This field is for validation purposes and should be left unchanged. Name First Name Last Name Company* Email* Job Title* Country (Choose an Option)* Country (Choose an Option)*AfghanistanAland IslandsAlbaniaAlgeriaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBolivia, Plurinational State ofBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei
- [Bacterial vs Viral](https://memed-staging.freshy.dev/bacterial-vs-viral/): [et_pb_section fb_built=”1″ disabled_on=”on|on|off” admin_label=”Section desktop” _builder_version=”4.25.0″ _module_preset=”default” background_color=”RGBA(255,255,255,0)” background_image=”https://memed-staging.freshy.dev/wp-content/uploads/newtopimage-copy-2.png” background_size=”contain” background_position=”top_center” custom_padding=”||175px||false|false” collapsed=”off” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ disabled_on=”on|on|off” admin_label=”Rowdesktop” _builder_version=”4.25.0″ _module_preset=”default” background_enable_image=”off” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.25.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https://memed-staging.freshy.dev/wp-content/uploads/logo-2-e1677679399285-1.png” title_text=”logo-2-e1677679399285″ _builder_version=”4.25.0″ _module_preset=”default” max_width=”200px” global_colors_info=”{}”][/et_pb_image][et_pb_text module_class=”h1toptext” _builder_version=”4.27.2″ _module_preset=”default” text_font_size=”20px” text_line_height=”1.5em” header_font=”HelveticaNeueLT Roman|700|||||||” header_text_align=”left” header_font_size=”45px” header_2_font=”HelveticaNeueLT Roman|700|||||||” header_2_text_align=”left” header_2_font_size=”45px” header_3_font=”HelveticaNeueLT Roman|700|||||||” header_3_text_align=”left” header_3_font_size=”45px” header_4_font=”HelveticaNeueLT Roman|700|||||||” header_4_text_align=”left” header_4_font_size=”45px” header_5_font=”HelveticaNeueLT Roman|700|||||||” header_5_text_align=”left”
- [News](https://memed-staging.freshy.dev/news/): [et_pb_section fb_built=”1″ _builder_version=”4.19.5″ _module_preset=”default” background_color=”#F6F6F6″ custom_padding=”0px||0px||true|false” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ use_custom_gutter=”on” gutter_width=”1″ make_equal=”on” _builder_version=”4.20.0″ _module_preset=”default” width=”100%” width_tablet=”100%” width_phone=”100%” width_last_edited=”on|tablet” max_width=”none” custom_padding=”0px||0px||true|false” global_colors_info=”{}”][et_pb_column type=”1_2″ module_class=”center-vertically” _builder_version=”4.20.0″ _module_preset=”default” custom_padding=”180px|5%|180px|6%|true|false” custom_padding_tablet=”50px|5%|50px|5%|true|true” custom_padding_phone=”50px|10%|50px|10%|true|true” custom_padding_last_edited=”off|desktop” global_colors_info=”{}”][et_pb_text content_tablet=” The immune system is built to communicate. Our mission is to listen. Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem
- [Press Releases](https://memed-staging.freshy.dev/press-releases/): Read the latest press releases from MeMed to stay updated on our new diagnostic tools, milestones, and contributions to host-response research.
- [Case Examples Old](https://memed-staging.freshy.dev/learning-center/case-examples-2/): Case Examples MeMed BV was validated in independent, double-blinded, multi-national clinical studies with 30 publications and over 20,000 patients. Below you can find examples of real-world cases, anonymized and simplified into short, animated videos showing the value of BV in different clinical scenarios: Patients Medical Centers Countries [brcr_image_carousel is_autoplay=”off” disabled_on=”on|off|off” admin_label=”DP Image Carousel – Desktop
- [Case Examples Old](https://memed-staging.freshy.dev/learning-center/case-examples-1/): Case Examples MeMed BV was validated in independent, double-blinded, multi-national clinical studies with 30 publications and over 20,000 patients. Below you can find examples of real-world cases, anonymized and simplified into short, animated videos showing the value of BV in different clinical scenarios: Patients Medical Centers Countries Case Examples Videos Click image to view video.
- [test](https://memed-staging.freshy.dev/test-2/): Case Examples
- [LEGAL: Privacy Policy](https://memed-staging.freshy.dev/privacy-policy/): Privacy Policy This Privacy Policy (“Policy“) governs the data collection, processing and usage made by MeMed Diagnostics Ltd. (“MeMed” or “us”, “our”, “we”) through our website. This Policy concerns the data we collect from individuals who access and use our website (“Users”, “you” or “your“). This Policy constitutes an integral part of the Terms and
- [Request Demo Thank You](https://memed-staging.freshy.dev/request-a-demo/thank-you/): Thank you for your inquiry! Your submission has been sent and a representative will follow up with you shortly. Check out more from MeMed below: Products Learning Center
- [Learning Center](https://memed-staging.freshy.dev/learning-center/): Explore MeMed's Learning Center for in-depth resources on our diagnostic test training, including videos, publications, webinars and case studies.
- [LANDING PAGE: MeMed Customer Toolkit](https://memed-staging.freshy.dev/memed-customer-toolkit/): MeMed BV Marketing Toolkit Welcome to the MeMed BV Marketing Toolkit! Here you’ll find a range of marketing templates to streamline your efforts and maximize your reach. With placeholders for your logo and contact information, these templates are easily customizable. When sharing on social media, reach out to us at smile@me-med.com, and we’ll reshare and
- [Request Demo Thank You Test](https://memed-staging.freshy.dev/request-a-demo/thank-you-test/): Thank you for your inquiry! Your submission has been sent and a representative will follow up with you shortly. Check out more from MeMed below: Products Learning Center
- [Suspected Sepsis](https://memed-staging.freshy.dev/suspected-sepsis/): Learn about MeMed's diagnostic solution for suspected sepsis, including rapid etiology assessment. With timely intervention, we can help improve patient outcomes.
- [AMR](https://memed-staging.freshy.dev/learning-center/amr/): Antimicrobial Resistance (AMR) occurs when bacteria no longer respond to antimicrobial medicines As a result of drug resistance, antibiotics become ineffective and infections become difficult or impossible to treat, increasing the risk of disease spread, severe illness, disability and death. Antibiotic Misuse is the main driver in the development of drug-resistance pathogens Approximately 30of antibiotics
- [MeMed BV for Physicians](https://memed-staging.freshy.dev/memed-bv-for-physicians/): Learn about MeMed, a leading diagnostics company specializing in differentiating bacterial from viral infections, sepsis management, and immune system decoding.
- [Landing Page: Stickers](https://memed-staging.freshy.dev/stickers/): Stickers
- [Auto Draft](https://memed-staging.freshy.dev/auto-draft/): Slide FDA Grants Breakthrough Device Designation to MeMed Severity™ Test for Patients with Suspected Sepsis Read More FDA Grants Breakthrough Device Designation to MeMed Severity™ Test for Patients with Suspected Sepsis Read More Slide The Value of MeMed BV in the Management of Patients with Suspected Sepsis Learn More The Value of MeMed BV in
- [Original Home Page](https://memed-staging.freshy.dev/original-home/): The immune system is built to communicate. Our mission is to listen. We apply machine learning to translate the complex signaling of the immune system into simple, actionable diagnostic insights. MeMed’s machine learning-based diagnostics address key clinical and medical challenges in infectious diseases and inflammatory disorders. MeMed BV Bacterial and viral infections are often clinically indistinguishable
- [Beyond the Score](https://memed-staging.freshy.dev/beyond-the-score/)
- [LANDING PAGE: MeMed at ECCMID](https://memed-staging.freshy.dev/2024-eccmid-storm/): Sign up for the STORM Simulator!
- [Thank You](https://memed-staging.freshy.dev/ga-util-popup/ga-util-healthcare-providers/thank-you/): Thank you for your form submission! Products Learning Center
- [UTILIZATION for Healthcare Providers](https://memed-staging.freshy.dev/ga-util-popup/ga-util-healthcare-providers/): Now the only reason to treat a bacterial infection is because there actually is one! In 15 minutes from a small sample, the FDA-cleared MeMed BV® computationally integrates the levels of three host immune proteins into a simple score indicating the likelihood of a bacterial immune response or co-infection versus a likely viral immune response.
- [Awareness for Healthcare Providers](https://memed-staging.freshy.dev/ga-aware-healthcare-providers/): MeMed BV Now the only reason to treat a bacterial infection is because there actually is one! In 15 minutes from a small sample, the FDA-cleared MeMed BV® computationally integrates the levels of three host immune proteins into a simple score indicating the likelihood of a bacterial immune response or co-infection versus a likely viral
- [Landing Page: Bodyville's Invisible Invaders A Tale of Bacteria and Viruses Video](https://memed-staging.freshy.dev/bodyvilles-invisible-invaders/): Bodyville’s Invisible Invaders: A Tale of Bacteria and Viruses “Bodyville’s Invisible Invaders” is a downloadable, engaging video for kids in waiting rooms. The video is an adventurous journey that illustrates bacterial and viral infections through the adventures of Vicky Virus, Benny Bacteria, and Dr. Doodle, who solves these mysteries with the MeMed BV test. Download
- [UTILIZATION for Patients](https://memed-staging.freshy.dev/ga-util-popup/ga-util-patients/): Ask your doctor if MeMed BV is right for you! MeMed BV® helps care providers quickly determine whether an infection is caused by a bacteria or virus, using a simple blood sample. This helps in the wise use of antibiotics, which is important for reducing antibiotic misuse and resistance​. Did you know that the symptoms
- [Awareness for Patients](https://memed-staging.freshy.dev/ga-aware-patients/): What is MeMed BV? MeMed BV® helps care providers quickly determine whether an infection is caused by a bacteria or virus, using a simple blood sample. This helps in the wise use of antibiotics, which is important for reducing antibiotic misuse and resistance​. Did you know that the symptoms of bacterial and viral illness are
- [Google Ads: UTILIZATION Pop Up](https://memed-staging.freshy.dev/ga-util-popup/): Now the only reason to treat a bacterial infection is because there actually is one! In 15 minutes from a small sample, the FDA-cleared MeMed BV® computationally integrates the levels of three host immune proteins into a simple score indicating the likelihood of a bacterial immune response or co-infection versus a likely viral immune response.
- [Google Ads: AWARENESS Pop Up](https://memed-staging.freshy.dev/ga-aware-popup/): MeMed BV Now the only reason to treat a bacterial infection is because there actually is one! In 15 minutes from a small sample, the FDA-cleared MeMed BV® computationally integrates the levels of three host immune proteins into a simple score indicating the likelihood of a bacterial immune response or co-infection versus a likely viral
- [LANDING PAGE: MeMed Customer Toolkit Form](https://memed-staging.freshy.dev/customer-toolkit/): MeMed BV Toolkit Please Sign In "*" indicates required fields Phone This field is for validation purposes and should be left unchanged. First name* Last name* Company Country* Country *AfghanistanAland IslandsAlbaniaAlgeriaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBolivia, Plurinational State ofBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChinese TaipeiChristmas IslandCocos (Keeling)
- [MeMed Core Values](https://memed-staging.freshy.dev/core-values/): Discover the core values that drive MeMed's commitment to innovative diagnostic solutions, including host response decoding and rapid detection of infection etiology.
- [Landing Page: How Does it Work Video](https://memed-staging.freshy.dev/video-how-does-it-work/): How Does MeMed BV Work? Run on the compact MeMed Key®, the FDA-cleared MeMed BV® is a novel, host response assay that can distinguish between bacterial and viral infections, delivering fast, easy and accurate results in 15 minutes from a serum or venous whole blood sample.* *MeMed BV on venous whole blood is 510K cleared. Currently available only
- [Landing Page: MeMed at AACC 2023](https://memed-staging.freshy.dev/memed-at-aacc-annual-scientific-meeting-symposium-chapters/): Real-world performance of MeMed BV:A host-response test for differentiating between bacterial and viral infection in adults and pediatrics Symposium at the 2023 AACC Annual Scientific Meeting Introduction David M. Engman, MD, PhDChair of Pathology Emeritus, Cedars Sinai Medical Center, Los AngelesProfessor of Pathology Emeritus, Northwestern University Feinberg School of Medicine, Chicago Validation of a Multi-Analyte
- [Events](https://memed-staging.freshy.dev/events/): Stay informed about upcoming MeMed events where we showcase our latest diagnostic technologies. Join us to learn more about our innovative technology breakthroughs.
- [LANDING PAGE: Respiratory Season](https://memed-staging.freshy.dev/respiratory-season/): Winter is coming! Are you ready for respiratory season? Emergency Departments brace for the inevitable surge in viral respiratory infections like COVID, RSV, and the flu as winter approaches. With cases poised to climb, are your operations streamlined to manage the influx? Don’t be caught unprepared. Discover how MeMed BV can help streamline your ED
- [LEGAL: Website Terms & Conditions](https://memed-staging.freshy.dev/terms-conditions/): Terms & Conditions Last Amended:March, 2022] These terms and conditions (“Terms”) are a legally binding agreement between MeMed Diagnostics Ltd. (“MeMed,” “we,” “us,” or “our”), and you, a user which access to or otherwise interact with our website, available at https://memed-staging.freshy.dev/. ACCEPTANCE OF THE TERMS: BY ACCESSING, BROWSING OR OTHERWISE USING OUR WEBSITE YOU ACKNOWLEDGE
- [LEGAL: MeMed Terms and Conditions for Purchase](https://memed-staging.freshy.dev/memed-terms-and-conditions-for-purchase/): MeMed Terms and Conditions for Purchase The following terms and conditions (the “Terms”) shall form an integral part of an issued purchase order (the “PO”) and shall govern the purchase of any goods, materials, products or services of any kind (“Deliverables”) ordered or purchased by MeMed Diagnostics Ltd. and any of its affiliates and related
- [LEGAL: Product Evaluation Terms](https://memed-staging.freshy.dev/memed-product-evaluation-terms/): Product Evaluation Terms These MeMed’s Products Evaluation Terms (“Terms”), and any MeMed US, Inc. (“MeMed”) written quotation or proposal prepared by MeMed specifically for you referencing these Terms and the other MeMed documentation referenced in these Terms, together comprise the entire contract between you and MeMed (“Agreement”) and supersede all other representations and understandings between
- [LANDING PAGE: MeMed BV from Whole Blood](https://memed-staging.freshy.dev/memed-bv-for-whole-blood/): MeMed BV Now from Whole Blood Introducing the next generation MeMed BV testNow FDA cleared in the US to include whole blood sample type MeMed BV Whole Blood Enhanced Patient Care Expanded Patient Access MeMed BV on whole blood expands access to a broader patient population, accelerates our mission of establishing it as the standard of
- [Products](https://memed-staging.freshy.dev/products/): Explore MeMed's range of diagnostic products, including rapid diagnostic tests and immunoassay analyzers. Learn how we are impacting infectious disease and sepsis patients to improving healthcare.
- [About Us](https://memed-staging.freshy.dev/about-us/): Learn about MeMed, a leading diagnostics company specializing in differentiating bacterial from viral infections, sepsis management, and immune system decoding.
- [Thank You](https://memed-staging.freshy.dev/memed-bv/thank-you/): Thank you! Check out more from MeMed below: Products Learning Center
- [Thank You](https://memed-staging.freshy.dev/thank-you/): Thank you! Check out more from MeMed: Products Learning Center
- [Thank You](https://memed-staging.freshy.dev/contact/thank-you/): Thank you for your inquiry! Your submission has been sent and a representative will follow up with you shortly. Check out more from MeMed below: Products Learning Center
- [Password](https://memed-staging.freshy.dev/password/): Password Recovery Recover your MeMed Key® password Looking for a quick guide to the MeMed BV score? "*" indicates required fields URL This field is for validation purposes and should be left unchanged. Looking for a quick guide to the MeMed BV score? First name* Last name* Email* Country (Choose an Option) Country (Choose

## *Learning Center*

- [C50-40 From Viral-Like Illness to Septic Shock: Diagnostic Support From a Host-Response Test](https://academic.oup.com/ajrccm/article/212/Supplement_1/aamag162.6215/8685709?guestAccessKey=#new_tab)
- [WEBINAR: The Case for MeMed BV: Antimicrobial Resistance and Antimicrobial Stewardship](https://memed-staging.freshy.dev/learningcenter/webinar-the-case-for-memed-bv-antimicrobial-resistance-and-antimicrobial-stewardship/)
- [WEBINAR: Differentiating Viral from Bacterial Infections with MeMed BV: Clinical Best](https://memed-staging.freshy.dev/wp-content/uploads/Differentiating-Viral-from-Bacterial-Infections-with-MeMed-BV-Clinical-Best-Practices-Case-Studies-and-Insights.mp4)
- [VIDEO: MeMed BV on MeMed Key](https://memed-staging.freshy.dev/wp-content/uploads/MeMed_Web_Video-low-res.mp4)
- [VIDEO: This Medical Startup Does the Impossible!](https://www.youtube.com/embed/sHCVRUaFOqI)
- [WEBINAR: Bacterial or Viral from Research to Clinical use of MeMed BV in the Emergency](https://memed-staging.freshy.dev/wp-content/uploads/Bacterial-or-viral-From-research-to-clinical-use-of-MeMed-BV-in-the-Emergency-Department.mp4)
- [VIDEO: Real World Performance of MeMed BV Workshop at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo](https://player.vimeo.com/video/849556300?h=fb7c99b4ed)
- [VIDEO: MeMed BV Training](https://memed-staging.freshy.dev/wp-content/uploads/20240130-clinicians-training-video1.mp4)
- [VIDEO PRESENTATION: Host-response Technology can Improve Antibiotic Treatment](https://memed-staging.freshy.dev/wp-content/uploads/MeMed-CEO-Co-founder-Dr.-Eran-Eden-lectures-@-ECCMID-2021.mp4)
- [VIDEO PRESENTATION: Is it a Bacterial or Viral Infection? Using Host Response Technologies to Decode the Immune System and Aid Antibiotic Stewardship](https://memed-staging.freshy.dev/wp-content/uploads/Dr.-Debra-Goff-and-Dr.-Eran-Eden-lecture-from-IDWeek-2021.mp4)
- [VIDEO: How MeMed Technology Works](https://memed-staging.freshy.dev/wp-content/uploads/MeMed_BV_MOA.mp4)
- [VIDEO PRESENTATION: A Host-based Assay Comprising TRAIL, IP-10 and CRP](https://memed-staging.freshy.dev/wp-content/uploads/Prof.-Susanna-Esposito-lectures-@-ECCMID-2021.mp4)
- [VIDEO PRESENTATION: A Host-based Assay Comprising TRAIL, IP-10 and CRP Outperforms Procalcitonin in Accurately Distinguishing Between Bacterial and Viral Infection in Febrile Children](https://memed-staging.freshy.dev/wp-content/uploads/Prof.-Susanna-Esposito-lectures-@-ECCMID-2021.mp4#new_tab)
- [VIDEO PRESENTATION: Disruptive Technology Award, AACC 2021](https://memed-staging.freshy.dev/wp-content/uploads/2021-AACC-Disruptive-Technology-Award-Finalist.mp4#new_tab)
- [VIDEO PRESENTATION: A Rapidly Measurable Host Assay Comprising TRAIL, IP-10 and CRP Has Potential to Reduce Antibiotic Overuse without Increasing Underuse in Adults With Suspected Lower Respiratory Tract Infection, CDiff Foundation 2021](https://memed-staging.freshy.dev/wp-content/uploads/CDIFF21.mp4)
- [VIDEO PRESENTATION: A Host Response Test (MMBV) for Differentiating Between Bacterial and Viral Infection has the Potential to Improve Antibiotic Stewardship in Patients With Suspected Sepsis](https://memed-staging.freshy.dev/wp-content/uploads/ANGEL-MMBV-in-suspected-sepsis1.mp4)
- [PUBLICATION: Validation of a Novel Assay to Distinguish Bacterial and Viral Infections](https://www.publications.aap.org/pediatrics/article-abstract/140/4/e20163453/38158/Validation-of-a-Novel-Assay-to-Distinguish?redirectedFrom=fulltext#new_tab)
- [PUBLICATION: Validation of a Multi-Analyte Immunoassay for Distinguishing Bacterial vs. Viral Infections in a Pediatric Cohort](https://www.sciencedirect.com/science/article/abs/pii/S0009898123001894#new_tab)
- [VIDEO ABSTRACT: Diagnostic Accuracy of a Real-Time Host-Protein Test for Infection](https://memed-staging.freshy.dev/wp-content/uploads/Spirit-4-minute-video-abstract.mp4)
- [PUBLICATION: Validation of a Whole Blood Machine Learning Strategy for Distinguishing Between Bacterial and Viral Infection in a Pediatric Hospital Setting](https://www.sciencedirect.com/science/article/pii/S2352551724000337?via=ihub#new_tab)
- [Surepoint Medical Center](https://memed-staging.freshy.dev/learningcenter/surepoint-medical-center/)
- [TrustCare Health](https://memed-staging.freshy.dev/learningcenter/trustcare-health/)
- [PUBLICATION: Update of a Clinical Prediction Model for Serious Bacterial Infections in Preschool Children by Adding a Host-protein-based Assay: A Diagnostic Study](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6782126/#new_tab)
- [PUBLICATION: Observational Cohort Study of IP-10’s Potential as a Biomarker to aid in Inflammation Regulation Within a Clinical Decision Support Protocol for Patients With Severe COVID-19](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0245296#new_tab)
- [PUBLICATION: TRAIL, IP-10, CRP Host-protein Signature Score Distinguishes Between Viral and Bacterial Infection in Sepsis Patients](https://academic.oup.com/jacamr/article/4/Supplement_2/dlac052.002/6596251?login=false#new_tab)
- [PUBLICATION: MeMed BV Testing in Emergency Department Patients Presenting With Febrile Illness Concerning for Respiratory Tract Infection](https://www.sciencedirect.com/science/article/abs/pii/S0735675722007276?via=ihub#new_tab)
- [PUBLICATION: Impact on Patient Management of a Novel Host Response Test for Distinguishing Bacterial and Viral Infections: Real World Evidence from the Urgent Care Setting](https://www.mdpi.com/2227-9059/11/5/1498#new_tab)
- [PUBLICATION: Natural Variability of TRAIL, IP-10, and CRP in Healthy Adults – The “HERACLES” Study](https://www.sciencedirect.com/science/article/pii/S1043466624000334#new_tab)
- [PUBLICATION: Distinguishing Bacterial Versus Non-bacterial Causes of Febrile Illness – A Systematic Review of Host Biomarkers](https://www.journalofinfection.com/article/S0163-4453(21)00085-2/fulltext)
- [PUBLICATION: Differential Serum and Urine CRP, IP-10, and TRAIL Levels in Pediatric Urinary Tract Infection](https://www.frontiersin.org/articles/10.3389/fped.2021.771118/full#new_tab)
- [PUBLICATION: Expression of TRAIL, IP-10, and CRP in Children With Suspected COVID-19 and Real-life Impact of a Computational Signature on Clinical Decision-making: A Prospective Cohort Study](https://link.springer.com/content/pdf/10.1007/s15010-023-01993-1.pdf#new_tab)
- [PUBLICATION: Host Test Based on TRAIL, IP-10 and CRP for Differentiating Bacterial and Viral Respiratory Tract Infections in Adults: Diagnostic Accuracy Study](https://memeddx.com/3J9rArb)
- [PUBLICATION: Host Biomarkers and Combinatorial Scores for the Detection of Serious and Invasive Bacterial Infection in Pediatric Patients with Fever Without Source](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0294032#new_tab)
- [PUBLICATION: Diagnostic Accuracy of a TRAIL, IP-10 and CRP Combination for Discriminating Bacterial and Viral Etiologies at the Emergency Department](https://www.journalofinfection.com/article/S0163-4453(16)30086-X/fulltext#new_tab)
- [PUBLICATION: Automating a New Host-protein Assay for Differentiating Bacterial From Viral Infection to Reduce Operator Hands-on Time](https://www.future-science.com/doi/full/10.2144/btn-2018-0028#new_tab)
- [PUBLICATION: Cost Impact Analysis of Novel Host-response Diagnostic for Patients With Community-acquired Pneumonia in the Emergency Department](https://www.tandfonline.com/doi/full/10.1080/13696998.2022.2026686?utm_source=linkedin&utm_medium=post&utm_campaign=HE#new_tab)
- [PUBLICATION: BV Score Differentiates Viral From Bacterial-viral Co-infection in Adenovirus PCR Positive Children](https://www.frontiersin.org/articles/10.3389/fped.2022.990750/full#new_tab)
- [PUBLICATION: Bacterial vs. Viral Etiology of Fever: A Prospective Study of a Host Score for Supporting Etiologic Accuracy of Emergency Department Physicians](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0281018#new_tab)
- [PUBLICATION: Diagnostic Accuracy of a Real-Time Host-Protein Test for Infection](https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2022-060441/194589/Diagnostic-Accuracy-of-a-Real-Time-Host-Protein?autologincheck=redirected&utm_source=linkedin&utm_medium=social&utm_campaign=spirit#new_tab)
- [PUBLICATION: Assessing the Febrile Child for Serious Infection: A Step Closer to Meaningful Rapid Results](https://publications.aap.org/pediatrics/article-abstract/140/4/e20171210/38083/Assessing-the-Febrile-Child-for-Serious-Infection?redirectedFrom=fulltext#new_tab)
- [PUBLICATION: Antibiotic Misuse In Respiratory Tract Infections in Children And Adults—A Prospective, Multicentre Study (TAILORED Treatment)](https://link.springer.com/article/10.1007/s10096-018-03454-2#new_tab)
- [PUBLICATION: An Immune-protein Signature Combining TRAIL, IP-10 and CRP for Accurate Prediction of Severe COVID-19 Outcome](https://www.medrxiv.org/content/10.1101/2021.06.27.21259196v1)
- [PUBLICATION: A Point-of-need Platform for Rapid Measurement of A Host-protein Score That Differentiates Bacterial From Viral Infection: Analytical Evaluation](https://www.sciencedirect.com/science/article/pii/S0009912022001151#new_tab)
- [PUBLICATION: A Rapid Host–Protein Test for Differentiating Bacterial from Viral Infection: Apollo Diagnostic Accuracy Study](https://onlinelibrary.wiley.com/doi/10.1002/emp2.13167#new_tab)
- [PUBLICATION: Assessment of MeMed BV Assays for Differentiating Between Bacterial and Viral Respiratory Infections](https://www.tandfonline.com/doi/full/10.1080/14737159.2024.2408743#new_tab)
- [PUBLICATION: A Multifaceted ‘omics’ Approach for Addressing the Challenge of Antimicrobial Resistance](https://www.futuremedicine.com/doi/full/10.2217/fmb.14.127#new_tab)
- [PUBLICATION: A Host-protein Based Assay to Differentiate Between Bacterial and Viral Infections in Preschool Children (Opportunity): A Double-blind, Multicentre, Validation Study](https://www.sciencedirect.com/science/article/abs/pii/S1473309916305199)
- [PUBLICATION: A Novel Host-protein Assay Outperforms Routine Parameters for Distinguishing Between Bacterial and Viral Lower Respiratory Tract Infections](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0120012)
- [PUBLICATION: A Host-Response Signature Based on TRAIL, IP-10 and CRP Addresses Antibiotic Misuse Driven by Diagnostic Uncertainty](https://memed-staging.freshy.dev/wp-content/uploads/A-Host-Response-Signature-Based-on-TRAIL-IP-10-and-CRP-Addresses-Antibiotic-Misuse-Driven-by-Diagnostic-Uncertainty.pdf)
- [PUBLICATION: A Host Signature Based on TRAIL, IP-10, and CRP for Reducing Antibiotic Overuse in Children by Differentiating Bacterial From Viral Infections: A Prospective, Multicentre Cohort Study](https://www.sciencedirect.com/science/article/pii/S1198743X21006212)
- [Poster: Implementation of a Host-Protein Test (MMBV) Into Routine Care for Children Hospitalized with Symptoms of Lower Respiratory Tract Infection](https://memed-staging.freshy.dev/wp-content/uploads/2235_IDWPOSTER.pdf)
- [PODCAST: Immune Response Can Guide COVID-19 Treatment](https://radio.foxnews.com/2020/08/04/immune-response-can-guide-covid-19-treatment/)
- [PODCAST: BioBoss #26 – Eran Eden: Co-Founder and CEO of MeMed](https://bioboss.buzzsprout.com/236855/5433820-26-eran-eden-co-founder-and-ceo-of-memed)
- [PODCAST: Is Your Kid’s Infection Bacterial or Viral? Eran Eden’s MeMed Can Tell](https://glorikian.com/is-your-kids-infection-bacterial-or-viral-eran-edens-memed-can-tell/)
- [Poster: Diagnostic Performance of a Rapid Host-Protein Test (MeMed BV) In Detecting Bacteremia in Children](https://memed-staging.freshy.dev/wp-content/uploads/2246_IDWeek-poster.pdf)
- [Physicians Premier ER](https://memed-staging.freshy.dev/videos/physicians-premier-er/)
- [MeMed BV Intro](https://memed-staging.freshy.dev/videos/memed-bv-intro/)
- [Implementation of a Rapid Host-Protein Diagnostic Test for Distinguishing Bacterial and Viral Infections in Adults Presenting to Urgent Care Centers: A Pragmatic Cohort Study](https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-025-03903-8)
- [Host-response testing with MeMed BV in Community-Acquired Pneumonia: An Economic Evaluation From the UK NHS Perspective](https://academic.oup.com/jacamr/article/7/1/dlaf016/8023371?searchresult=1&login=false)
- [From Pathogen to Infectious Disease Diagnosis: Test Determines Between Bacterial and Viral Infections in 15 Minutes](https://www.contagionlive.com/view/from-pathogen-to-infectious-disease-diagnosis-test-determines-between-bacterial-and-viral-infections-in-15-minutes)
- [Effect of Host- Protein Test (TRAIL/IP- 10/CRP) on Antibiotic Prescription and Emergency Department or Urgent Care Center Return Visits: The JUNO Pilot Randomized Controlled Trial](https://memed-staging.freshy.dev/wp-content/uploads/2025-Singer-AEM-JUNO-RCT.pdf)
- [Diagnostic Insights: Triverity vs. MeMed BV](https://memed-staging.freshy.dev/wp-content/uploads/Diagnostic-Insights-episode-3-Triverity-vs.-MeMed-BV.mp3)
- [ABSTRACT: Validation Of A Novel Semi-quantitative Immunoassay To Differentiate Bacterial Vs Viral Infections From Serum Samples](https://memed-staging.freshy.dev/wp-content/uploads/ECCMId-2022-Validation-of-a-Novel-Semi-Quantitative-Immunoassay-to-Differentiate-Bacterial-vs-Viral-Infections-from-Serum-Samples.pdf)
- [Abstract: Verification and Validation Study for a Host Response Assay Based on TRAIL, IP-10, and CRP: Application to Pediatric Emergency Department](https://academic.oup.com/clinchem/article/70/Supplement_1/hvae106.238/7760972)
- [Development of a Reference Standard to Assign Bacterial Versus Viral Infection Etiology Using an All-Inclusive Methodology for Comparison of Novel Diagnostic Tool Performance](https://pubmed.ncbi.nlm.nih.gov/39750735/#new_tab)
- [Diagnostic Insights: Lessons from the Juno Trial](https://memed-staging.freshy.dev/wp-content/uploads/JUNO-Trial_-Host-Protein-Test-Impact-on-Antibiotic-Use.mp3)
- [Diagnostic Insights: Pneumonia, Precision and Pounds: The Economic Power of Accurate Diagnosis with MeMed BV](https://memed-staging.freshy.dev/wp-content/uploads/MeMed-BV-Cost-Effectiveness-in-Community-Acquired-Pneumonia-Management-FINAL.mp3)
- [ABSTRACT: TRAIL, IP-10, CRP Host-protein Signature Score Distinguishes Between Viral And Bacterial Infection In Sepsis Patients](https://memed-staging.freshy.dev/wp-content/uploads/BSAC-2022-TRAIL-IP-10-CRP-Signature-score-distinguishes-B.V.-infection-sepsis.pdf)
- [ABSTRACT: Using MeMed BV® to reduce antibiotic us for low-risk CAP](https://memed-staging.freshy.dev/wp-content/uploads/Le_PAS-4.28.23.pdf)
- [ABSTRACT: Validation of a multi analyte immunoassay for distinguishing bacterial vs. viral infections in a pediatric cohort](https://memed-staging.freshy.dev/wp-content/uploads/Texas-Childrens-Abstract-AACC-2023.pdf#new_tab)
- [Abstract: Using a Host-Protein Test (Based on TRAIL/IP-10/CRP) to Assess the Likelihood of Bacterial Infection in Patients with Suspected Sepsis](https://academic.oup.com/clinchem/article/71/Supplement_1/hvaf086.290/8270113#new_tab)
- [ABSTRACT: Real-world Use Of A Novel Host-response Test To Aid Physicians In Distinguishing Between Bacterial And Viral Infections At Outpatient Urgent Care Centers](https://www.me-med.com/wp-content/uploads/545_IDWeekPoster.pdf#new_tab)
- [ABSTRACT: Real-World Impact of a Novel Host Response Test for Distinguishing Between Bacterial and Viral Infections in Pediatric Patients at Ten Urgent Care Centers](https://academic.oup.com/ofid/article/10/Supplement_2/ofad500.921/7448315#new_tab)
- [Abstract: The Association of the MeMed BV Test with Radiographic Pneumonia in Children](https://2024.pas-meeting.org/fsPopup.asp?PosterID=646904&mode=posterInfo#new_tab)
- [Abstract: Pilot Evaluation of a Host-Protein Test in Emergency Department Patients Who Trigger a Sepsis Alert](https://www.annemergmed.com/article/S0196-0644(25)00460-3/fulltext#new_tab)
- [ABSTRACT: Leveraging The Immune Response To Improve Outbreak Management: Derivation Of A Rapidly Measurable Host-protein Signature For Stratifying Severity Of COVID-19 Patients](https://www.me-med.com/wp-content/uploads/MeMed-Abstract-STRATIFYING-SEVERITY-OF-COVID-19-PATIENTS.pdf#new_tab)
- [Abstract: Impact of a Novel Host-Response Diagnostic on ED Antibiotic Decision-Making](https://www.me-med.com/wp-content/uploads/Published-abstract-Word.pdf#new_tab)
- [Abstract: MeMed Severity™: A Host-Protein Signature for Risk Stratification in Emergency Department Patients with Suspected Sepsis](https://academic.oup.com/clinchem/article/71/Supplement_1/hvaf086.246/8270224#new_tab)
- [ABSTRACT: Host-Protein Score (integrating TRAIL, IP-10, CRP) Distinguishes Between Bacterial And Viral Infection In Suspected Sepsis Patients](https://www.me-med.com/wp-content/uploads/MHSRS-2022-Sepsis-poster-09-08-2022_FINAL.pdf#new_tab)
- [ABSTRACT: Host-protein Score (Integrating TRAIL, IP-10, CRP) Distinguishes Between Viral And Viral-bacterial Coinfection In Adult Patients Testing Positive For Viral Detection](https://www.me-med.com/wp-content/uploads/ASM22-poster-31-MAY-2022.pdf#new_tab)
- [Abstract: Host-Protein Test Impact on Antibiotic Prescription Rates in Adults With Suspected Lower Respiratory Tract Infection](https://www.annemergmed.com/article/S0196-0644(24)00490-6/fulltext)
- [Abstract: Host-Protein Test in Routine Emergency Department Practice: Impact on Antibiotic Prescription, Admission, and Emergency Department Return](https://www.annemergmed.com/article/S0196-0644(25)00694-8/fulltext#new_tab)
- [Abstract: Impact of a Host-Protein Test on Antibiotic Use and Healthcare Costs in LRTI: JUNO RCT Sub-Analysis](https://memed-staging.freshy.dev/learningcenter/abstract-impact-of-a-host-protein-test-on-antibiotic-use-and-healthcare-costs-in-lrti-juno-rct-sub-analysis/)
- [ABSTRACT: BV Score’s Performance When Applied According To Indications For Use As Part Of Routine Care For Children Presenting To The Ed With Fever Without Source (Spirit Study Sub Analysis)](https://www.me-med.com/wp-content/uploads/ESPID-2022-ORAL-BV-SCORES-PERFORMANCE-WHEN-APPLIED-ACCORDING-TO-INDICATIONS-FOR-USE-AS-PART.pdf#new_tab)
- [ABSTRACT: BV Score (based on TRAIL, IP-10 and CRP) Accurately Distinguishes Between Bacterial and Viral Infection in Febrile Children: A Multi-Cohort Analysis](https://www.me-med.com/wp-content/uploads/2022-IDWeek-SK-BV-Score-based-on-TRAIL-IP10-and-CRP-Accurately-Distinguishes-Between-Bacterial-and-Viral-Infection-in-Febrile.pdf#new_tab)
- [ABSTRACT: Clinical impact of a near patient assay capable of discriminating between viral or bacterial lower respiratory tract infection in ambulatory adult patients a pilot study](https://www.me-med.com/wp-content/uploads/ECCMID-poster-Oxford_Final.pdf#new_tab)
- [ABSTRACT: Comparison between blood culture and MeMed BV test results](https://www.me-med.com/wp-content/uploads/Zuretti-A.-Comparison-between-blood-culture-and-MeMed-BV-test-results.pdf#new_tab)
- [ABSTRACT: Diagnostic Test Accuracy of TRAIL, IP-10 and C-RP Biomarker Combination (MeMed BV Test) for Discrimination of Viral vs. Bacterial Infections Among Emergency Department Patients with Febrile Illness: A Systematic Review and Meta-Analysis](https://academic.oup.com/ofid/article/10/Supplement_2/ofad500.912/7448468#new_tab)
- [Abstract: Differentiating Bacterial Versus Viral Infections in Elderly Patients With Suspected UTI: A Pilot Study](https://www.annemergmed.com/article/S0196-0644(25)00739-5/fulltext#new_tab)
- [ABSTRACT: A Rapidly Measurable Host Assay Comprising TRAIL, IP-10 AND CRP Has Potential To Reduce Antibiotic Overuse Without Increasing Underuse In Adults With Suspected Lower Respiratory Tract Infection](https://www.me-med.com/wp-content/uploads/MeMed-Abstract-Observer-Study-BV.pdf#new_tab)
- [ABSTRACT: A TRAIL, IP-10, CRP Host-protein Score Distinguishes Viral From Viral-bacterial Co-infections In Adult Patients Testing Positive For Viral Detection](https://www.me-med.com/wp-content/uploads/RCEM_Poster_October-2022_QR-code.pdf#new_tab)
- [ABSTRACT: Analytical validation of whole blood suitability for MeMed BV, a host-protein test for differentiating between bacterial and viral infection](https://www.me-med.com/wp-content/uploads/Simon-E.-Analytical-validation-of-whole-blood-suitability-for-MeMed-BV.pdf#new_tab)
- [Abstract: Bacterial Versus Viral Score Test: Evaluating Potential for Antibiotic Stewardship in Pediatrics](https://www.me-med.com/wp-content/uploads/PIDS-AMS-BactVsViral-Score-Poster-Niles-2024.pdf)
- [ABSTRACT: An Adjunct Bio-Array that Rapidly Differentiates Viral from Bacterial Sources Can Improve Quality of Care in Oncology Patients Presenting to Emergency Departments (EDs) with Respiratory Illnesses](https://www.sciencedirect.com/science/article/abs/pii/S0736467924001070#new_tab)
- [ABSTRACT: A Host-based Assay Comprising TRAIL, IP10, and CRP Can Improve Antibiotic Treatment Decisions For Viral PCR Positive Children By Accurately Ruling Out Co-infection](https://www.me-med.com/wp-content/uploads/ESPID-2021-A-host-based-assay-comprising-TRAIL-IP10-and-CRP-can-improve-antibiotic-treatment-decisions-for-viral-PCR-positive-children.pdf#new_tab)
- [ABSTRACT: A Host‐protein Test Based On TRAIL, IP‐10 and Differentiates Between Adenoviral And Bacterial‐Adenoviral Co‐infections In Children With Positive PCR‐adenovirus Detection](https://www.me-med.com/wp-content/uploads/ESPID-2022-A-HOST-PROTEIN-TEST-BASED-ON-TRAIL-IP-10-AND-CRP-DIFFERENTIATES-BETWEEN-ADENOVIRAL.pdf#new_tab)
- [ABSTRACT: A new test, based on the measure of three non microbial host proteins, for the differentiation between bacterial and viral infections](https://www.me-med.com/wp-content/uploads/Alonso-R.-et-al._-Poster-ECCMID-2023.pdf#new_tab)
- [Abstract: A Rapid Host-Response Test Supports Antimicrobial Stewardship at a Micro-Hospital Emergency Department](https://academic.oup.com/clinchem/article/70/Supplement_1/hvae106.409/7760706#new_tab)
- [Abstract: A Novel Host-Response Tool for Risk Stratification in Adults With Suspected Sepsis: MeMed Severity](https://www.annemergmed.com/article/S0196-0644(25)00423-8/fulltext#new_tab)
- [ABSTRACT: A host protein test based on TRAIL, IP-10 and CRP for differentiating between bacterial and viral infection has potential to improve patient selection for blood culture utilization](https://www.me-med.com/wp-content/uploads/Apollo-poster_EIM22.pdf#new_tab)
- [VIDEO PRESENTATION: A Rapidly Measurable Host Assay Comprising TRAIL, IP-10 and CRP Has Potential to Reduce Antibiotic Overuse without Increasing Underuse in Adults With Suspected Lower Respiratory Tract Infection, CDiff Foundation 2021](https://memed-staging.freshy.dev/wp-content/uploads/CDIFF21.mp4#new_tab)
- [TrustCare Health](https://memed-staging.freshy.dev/wp-content/uploads/trust_healthcare-1080p.mp4)
- [Surepoint Medical Center](https://memed-staging.freshy.dev/wp-content/uploads/surepoint_er_v11-1080p.mp4#new_tab)
- [PUBLICATION: A Host-protein Based Assay to Differentiate Between Bacterial and Viral Infections in Preschool Children (Opportunity): A Double-blind, Multicentre, Validation Study](https://www.sciencedirect.com/science/article/abs/pii/S1473309916305199)
- [Poster: Implementation of a Host-Protein Test (MMBV) Into Routine Care for Children Hospitalized with Symptoms of Lower Respiratory Tract Infection](https://memed-staging.freshy.dev/wp-content/uploads/2235_IDWPOSTER.pdf)
- [Physicians Premier ER](https://memed-staging.freshy.dev/videos/physicians-premier-er/)
- [Effect of Host- Protein Test (TRAIL/IP- 10/CRP) on Antibiotic Prescription and Emergency Department or Urgent Care Center Return Visits: The JUNO Pilot Randomized Controlled Trial](https://memed-staging.freshy.dev/wp-content/uploads/2025-Singer-AEM-JUNO-RCT.pdf)
- [Diagnostic Insights: Triverity vs. MeMed BV](https://memed-staging.freshy.dev/wp-content/uploads/Diagnostic-Insights-episode-3-Triverity-vs.-MeMed-BV.mp3)
- [Abstract: Using a Host-Protein Test (Based on TRAIL/IP-10/CRP) to Assess the Likelihood of Bacterial Infection in Patients with Suspected Sepsis](https://academic.oup.com/clinchem/article/71/Supplement_1/hvaf086.290/8270113#new_tab)
- [ABSTRACT: The Performance Of The BV Score For Differentiating Between Bacterial And Viral Infection Is Robust To Methodological Alternatives In Building The Reference Standard](https://www.me-med.com/wp-content/uploads/ESPID-2022-Autopilot-final-THE-PERFORMANCE-OF-THE-BV-SCORE-FOR-DIFFERENTIATING-BETWEEN-BACTERIAL-AND-VIRAL.pdf#new_tab)
- [ABSTRACT: Real-World Impact of a Novel Host Response Test for Distinguishing Between Bacterial and Viral Infections in Pediatric Patients at Ten Urgent Care Centers](https://academic.oup.com/ofid/article/10/Supplement_2/ofad500.921/7448315#new_tab)
- [Abstract: Real World Experience Using a Rapid Test to Distinguish Bacterial From Viral Infection in the Emergency Department](https://www.annemergmed.com/article/S0196-0644(24)00822-9/fulltext#new_tab)
- [Abstract: Real - World Impact of MeMed BV, a Rapid Host Response Test for Distinguishing Bacterial and Viral Infections, in an Urgent Care Network](https://www.me-med.com/wp-content/uploads/Maccabi-Adults-Poster-ECCMID-2024-Shared-3.pdf#new_tab)
- [Abstract: Pilot Evaluation of a Host-Protein Test in Emergency Department Patients Who Trigger a Sepsis Alert](https://www.annemergmed.com/article/S0196-0644(25)00460-3/fulltext#new_tab)
- [Abstract: MeMed Severity™: A Host-Protein Signature for Risk Stratification in Emergency Department Patients with Suspected Sepsis](https://academic.oup.com/clinchem/article/71/Supplement_1/hvaf086.246/8270224#new_tab)
- [ABSTRACT: Leveraging The Immune Response To Improve Outbreak Management: Derivation Of A Rapidly Measurable Host-protein Signature For Stratifying Severity Of COVID-19 Patients](https://www.me-med.com/wp-content/uploads/MeMed-Abstract-STRATIFYING-SEVERITY-OF-COVID-19-PATIENTS.pdf#new_tab)
- [Abstract: Real World Experience Using a Rapid Test to Distinguish Bacterial From Viral Infection in the Emergency Department](https://www.annemergmed.com/article/S0196-0644(24)00822-9/fulltext#new_tab)
- [ABSTRACT: MeMed BV Distinguishes Between Viral And Bacterial Infection In Sepsis Patients](https://www.me-med.com/wp-content/uploads/ECCMID-2022-MeMed-BV-Distinguishes-between-Viral-and-Bacterial-Infection-in-Sepsis-Patients.pdf#new_tab)
- [ABSTRACT: MeMed BV Distinguishes Between Viral And Bacterial Infection In Sepsis Patients](https://www.me-med.com/wp-content/uploads/MeMed-BV-Distinguishes-Between-Viral-and-Bacterial-Infection-in-Sepsis-Patients-Einav-Simon-B-239.pdf#new_tab)
- [Abstract: Impact of a Host-Protein Test on Antibiotic Use and Healthcare Costs in LRTI: JUNO RCT Sub-Analysis](https://www.annemergmed.com/article/S0196-0644(25)00736-X/fulltext#new_tab)
- [Abstract: Host-Protein Test in Routine Emergency Department Practice: Impact on Antibiotic Prescription, Admission, and Emergency Department Return](https://www.annemergmed.com/article/S0196-0644(25)00694-8/fulltext#new_tab)
- [Abstract: Differentiating Bacterial Versus Viral Infections in Elderly Patients With Suspected UTI: A Pilot Study](https://www.annemergmed.com/article/S0196-0644(25)00739-5/fulltext#new_tab)
- [PUBLICATION: Chapter 10 - Infection and Inflammation: A Double-Edged Sword](https://www.sciencedirect.com/science/article/abs/pii/B9780323991308000167?via=ihub#new_tab)
- [Abstract: Real - World Impact of MeMed BV, a Rapid Host Response Test for Distinguishing Bacterial and Viral Infections, in an Urgent Care Network](https://www.me-med.com/wp-content/uploads/Maccabi-Adults-Poster-ECCMID-2024-Shared-3.pdf#new_tab)
- [ABSTRACT: Host-Protein Score (Integrating TRAIL, IP-10, CRP) Distinguishes Between Viral and Viral-Bacterial Co-infection in Adult Patients Testing Positive for Viral Detection](https://www.me-med.com/wp-content/uploads/AACC22-poster-JUN-9-2022-Host-Protein-Score-Integrating-TRAIL-IP-10-CRP-Distinguishes-Between-Viral-and-Viral-Bacterial-Co-infection-in-Adult-Patients-Te.pdf#new_tab)
- [WEBINAR: The Case for MeMed BV: Antimicrobial Resistance and Antimicrobial](https://memed-staging.freshy.dev/wp-content/uploads/Kevin-Garey-Webinar.mp4)
- [VIDEO PRESENTATION: Is it a Bacterial or Viral Infection? Using Host-Response](https://memed-staging.freshy.dev/wp-content/uploads/2021-09-28-Theater-2-Main-Session-5-MeMed-720p-2.mp4)

## Press Release

- [MeMed Completes Development of the First Computational Host-Response Test Using a Fingerstick Sample to Differentiate Bacterial and Viral Infections: MeMed BV Flex™](https://memed-staging.freshy.dev/press_release/memed-completes-development-of-first-ever-fingerstick-host-response-test-for-rapid-differentiation-of-bacterial-and-viral-infections/): —MeMed BV Flex™ simultaneously integrates semi-quantitative measurements of multiple host proteins, paired with machine learning computational algorithms, to deliver a score in ~15 minutes from just a few drops of blood— —Designed for use in decentralized settings, the test has been analytically verified in a study to deliver results comparable to standard laboratory method—
- [New Evidence on MeMed BV’s Role in Supporting Emergency Medicine Clinical Decisions Unveiled at ACEP 2025](https://memed-staging.freshy.dev/press_release/new-evidence-on-memed-bvs-role-in-supporting-emergency-medicine-clinical-decisions-unveiled-at-acep-2025/): — Real-world data and KOL insights highlight MeMed BV’s supportive role in emergency medicine — ANDOVER, Mass. & HAIFA, Israel--(BUSINESS WIRE)--MeMed, a leader in host-response diagnostics, announced today that several oral presentations at the upcoming American College of Emergency Physicians (ACEP) Scientific Assembly 2025 will showcase the growing body of clinical evidence supporting the
- [MeMed BV Surpasses 100,000 Patient Tests, Underscoring Adoption of Rapid Host-Response Diagnostics](https://memed-staging.freshy.dev/press_release/100k-patient-tests/): — Milestone Achieved Through Growing Clinical Evidence Demonstrating Real-World Impact on Infection Management — — MeMed and Physicians Premier Celebrated Milestone Event in Corpus Christi, Texas — MeMed celebrates global clinical milestone for MeMed BV test with Physicians Premier ER. From left to right: Teri Cardenas, CEO, Physicians Premier ER; Tal Avziz, VP,
- [MeMed BV Proven to Optimize Antibiotic Use, Outperform Standard Care, and Cut Costs in New Studies](https://memed-staging.freshy.dev/press_release/memed-bv-proven-to-optimize-antibiotic-use-outperform-standard-care-and-cut-costs-in-new-studies/): MeMed BV Proven to Optimize Antibiotic Use, Outperform Standard of Care, and Cut Costs in New Studies — Three New Peer-Reviewed Studies Confirm MeMed BV’s Clinical and Economic Value Across Urgent Care, Emergency Settings, and Hospitals — ANDOVER, Mass. & HAIFA, Israel--(BUSINESS WIRE)--MeMed, a leader in host-response diagnostics, today announced the publication of three new
- [MeMed Expands Advisory Board with Key Leaders to Advance Host-Response Diagnostics for Sepsis and AMR](https://memed-staging.freshy.dev/press_release/memed-expands-advisory-board-with-key-leaders-to-advance-host-response-diagnostics-for-sepsis-and-amr/): — Renowned Experts Beat Müller, Dave Hickey, and David Shulkin Join MeMed’s Advisory Board — January 09, 2025 07:30 AM Eastern Standard Time ANDOVER, Mass. & HAIFA, Israel--(BUSINESS WIRE)--MeMed, a leader in host-response diagnostics, today announced the addition of three distinguished experts to its advisory board to accelerate its mission of addressing the global challenges of
- [FDA Grants Breakthrough Device Designation to MeMed Severity Test for Patients with Suspected Sepsis](https://memed-staging.freshy.dev/press_release/fda-grants-breakthrough-device-designation-to-memed-severity-test-for-patients-with-suspected-sepsis/): FDA Grants Breakthrough Device Designation to MeMed Severity Test for Patients with Suspected Sepsis —Major Development Milestone Reinforces MeMed’s Leadership in Host-Response Diagnostics— —FDA Endorsement Accelerates Product Development and Market Readiness— ANDOVER, Mass. & HAIFA, Israel--(BUSINESS WIRE)--MeMed, a leader in the emerging field of advanced host response technologies, today announced that the FDA has granted
- [MeMed BV Test Demonstrates Antibiotic Overuse Reduction in First US Interventional Trial](https://memed-staging.freshy.dev/press_release/memed-bv-test-demonstrates-antibiotic-overuse-reduction-in-first-us-interventional-trial/): MeMed BV Test Demonstrates Antibiotic Overuse Reduction in First US Interventional Trial —First Multi-Center Randomized Controlled Clinical Trial in the US to Show MeMed BV's Impact on Reducing Unnecessary Antibiotics, Supporting Clinical Decision-Making— — Preliminary Data Analysis Presented at ACEP24 Scientific Assembly in Las Vegas— HAIFA, Israel, Sept. 30, 2024 /PRNewswire/ -- MeMed, a leader in
- [DiaSorin Launches LIAISON<sup>®</sup> MeMed BV<sup>®</sup>, the First High Throughput Blood Test to Differentiate Between Bacterial and Viral Infections, in Countries Accepting the CE Mark](https://memed-staging.freshy.dev/press_release/diasorin-launches-liason-memed-bv-the-first-high-throughput-blood-test-to-differentiate-between-bacterial-and-viral-infections-in-countries-accepting-the-ce-mark/): LIAISON® MeMed BV® is an immune system based protein signature test for distinguishing between bacterial and viral infections The test was developed following the licensing agreement signed with MeMed as announced in September 2020 The new test is available on the LIAISON® XL platforms in countries that accept CE Mark and U.S. Food and Drug
- [Beckman Coulter and MeMed Extend Partnership Advancing Host Immune Response Diagnostics](https://memed-staging.freshy.dev/press_release/beckman-coulter-and-memed-extend-partnership-advancing-host-immune-response-diagnostics/): Beckman Coulter and MeMed Extend Partnership Advancing Host Immune Response Diagnostics Beckman Coulter Now an Authorized Distributor of MeMed Key Immunoassay System and MeMed BV Assay Progress Continues on Original Collaboration to Develop a MeMed BV-Based Assay for use on Beckman Coulter Immunoassay Analyzers BREA, Calif. and HAIFA, Israel, May 7, 2024 –Beckman Coulter Diagnostics,
- [MeMed Further Solidifies Board of Directors With New Appointment](https://memed-staging.freshy.dev/press_release/memed-bolsters-leadership-team-3/): MeMed Further Solidifies Board of Directors Appointing Scott Garrett HAIFA, Israel; BOSTON, MA – 6 November, 2023 – MeMed, a leader in host response technologies, today announces the appointment of Scott Garrett, to its Board of Directors. Scott Garrett is currently a Senior Operating Partner at Water Street Healthcare Partners, a private equity firm focused solely
- [MeMed Bolsters Leadership Team](https://memed-staging.freshy.dev/press_release/memed-bolsters-leadership-team-2/): MeMed Bolsters Leadership Team With Appointment of Ori Hadomi as Chairman and Peter Scheu as President of MeMed US Hebrew Translation HAIFA, Israel; BOSTON, MA – 6 November, 2023 – MeMed, a leader in host response technologies, today announces the appointment of Mr. Ori Hadomi as Chairman of the Board of Directors and Mr. Peter
- [MeMed Awarded US BARDA Contract](https://memed-staging.freshy.dev/press_release/memed-awarded-us-barda-contract/): MeMed Awarded US BARDA Contract to Demonstrate Clinical Utility of the FDA-cleared MeMed BV® Test for Distinguishing Bacterial From Viral Infections Contract awarded under the BARDA DRIVe (Division of Research, Innovation, and Ventures) initiative to harness a patient's systemic response to inform on health threats and clinical impact Hebrew Translation TIRAT CARMEL, Israel; BOSTON, MA, 24 October, 2023 –MeMed,
- [Clinical Data Validate Pioneering MeMed BV<sup>®</sup>  Technology Improves Diagnosis of Pediatric Patients with Fever in the Emergency Department](https://memed-staging.freshy.dev/press_release/clinical-data-validate-pioneering-memed-bv-technology-improves-diagnosis-of-pediatric-patients-with-fever-in-the-emergency-department/): Hebrew Translation Bacterial and viral infections are often clinically indistinguishable, leading to inappropriate patient management and antibiotic misuse MeMed BV® is the first FDA-cleared host-immune response assay to accurately distinguish between the two in just 15 minutes PETAH TIKVA, Israel and HAIFA, Israel; April 18, 2023 – MeMed, a leader in the emerging field of advanced
- [Nutex Health Announces Agreement with MeMed to Adopt Pioneering MeMed BV<sup>®</sup> Test Across its Network of 19 sites](https://memed-staging.freshy.dev/press_release/nutex-health-announces-agreement-with-memed-to-adopt-pioneering-memed-bv-test-across-its-network-of-19-sites/): Following successful partnerships with Tucson ER & Hospital and Tulsa ER & Hospital, Nutex Health will expand access to 19 hospitals to pioneering FDA-cleared technology that distinguishes viral from bacterial infection in 15 minutes HOUSTON and HAIFA, Israel, May 25, 2023 – Nutex Health Inc. (“Nutex Health”) (NASDAQ: NUTX), a distinguished physician-led, technology-enabled integrated healthcare delivery system, and MeMed, a pioneer in the burgeoning field of advanced host response
- [FDA Clears MeMed BV Direct from Whole Blood](https://memed-staging.freshy.dev/press_release/fda-clears-memed-bv-direct-from-whole-blood/): FDA Clears Pioneering MeMed BV Test Direct from Whole Blood Allowing Faster Time to Result and Broader Patient Access when Distinguishing Bacterial from Viral Infections Opens up testing to decentralized settings including urgent care centers which see 100 million patient visits for potential infections in the US annually Significant milestone towards making bacterial versus viral
- [Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Bacterial and Viral Infections](https://memed-staging.freshy.dev/press_release/beckman-coulter-and-memed-to-expand-access-to-proven-host-immune-response-diagnostic-able-to-distinguish-between-bacterial-and-viral-infections/): Collaboration to Add MeMed BV to Beckman Coulter Test Menu for use on Access Family of Immunoassay Analyzers BREA, CALIF., and HAIFA, Israel – January 31, 2023 – Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response technologies, announced today a strategic partnership to
- [Tulsa ER & Hospital Adopts Trailblazing MeMed BV Test](https://memed-staging.freshy.dev/press_release/tulsa-er-hospital-adopts-trailblazing-memed-bv-test/): Tulsa ER & Hospital is the first hospital facility in Oklahoma to adopt the FDA-approved technology that distinguishes viral from bacterial infections in 15 minutes HAIFA, Israel and TULSA, Oklahoma, December 22, 2022 – MeMed, a leader in the emerging field of advanced host-response technologies, and Tulsa ER & Hospital, a physician-managed facility with a mission to restore the provider
- [Tucson ER & Hospital Adopts Trailblazing MeMed BV Test](https://memed-staging.freshy.dev/press_release/tucson-er-hospital-adopts-trailblazing-memed-bv-test/): Tucson ER & Hospital Adopts Trailblazing MeMed BV® Test Tucson ER & Hospital is the first community-based, stand-alone ER and Hospital facility to adopt the FDA-cleared technology that distinguishes viral from bacterial infection in 15 minutes HAIFA, Israel and TUCSON, Arizona, October 25, 2022 – MeMed, a leader in the emerging field of advanced host-response
- [Dr. Sergey Motov at Maimonides Medical Center to Host Webinar on Using MeMed BV® in the Emergency Department to Rapidly Differentiate Bacterial and Viral Infections](https://memed-staging.freshy.dev/press_release/dr-sergey-motov-at-maimonides-medical-center-to-host-webinar-on-using-memed-bv-in-the-emergency-department-to-rapidly-differentiate-bacterial-and-viral-infections/): Dr. Sergey Motov at Maimonides Medical Center to Host Webinar on using MeMed BV® in the Emergency Department to rapidly differentiate bacterial and viral infections HAIFA, Israel, 13 July, 2022 – MeMed (or “the Company”), a leader in the emerging field of advanced host-response technologies, is pleased to announce that Dr. Sergey Motov, Research Director at the Department of Emergency Medicine at Maimonides Medical Center, will host a
- [MeMed to Participate in Upcoming Conferences](https://memed-staging.freshy.dev/press_release/memed-to-participate-in-upcoming-conferences/): HAIFA, Israel, April 29, 2022 – MeMed (or “the Company”), a leader in the emerging field of advanced host-response technologies, today announces that it will be participating in the following upcoming conferences: Urgent Care Association Annual Convention (UCA) Date: 30 April - 4 May, 2022 Booth 518 Location: Caesars Palace, Las Vegas, NV American Society
- [MeMed to Host Webinar on Best Practice Clinical Use of MeMed BV® for Differentiating Viral from Bacterial Infections on April 28, 2022](https://memed-staging.freshy.dev/press_release/memed-to-host-webinar-on-best-practice-clinical-use-of-memed-bv-for-differentiating-viral-from-bacterial-infections-on-april-28-2022/): HAIFA, Israel, April 21, 2022 – MeMed (or “the Company”), a leader in the emerging field of advanced host-response technologies, today announces that it will host a webinar entitled “Differentiating Viral from Bacterial Infections with MeMed BV: Clinical Best Practices, Case Studies and Insights” aimed at solving challenging clinical cases and associated antibiotic treatment decisions in the emergency department.
- [MeMed to Host Integrated Symposium at the 32nd European Congress of Clinical Microbiology and Infectious Diseases Conference 23 April 2022](https://memed-staging.freshy.dev/press_release/memed-to-host-integrated-symposium-at-the-32nd-european-congress-of-clinical-microbiology-and-infectious-diseases-conference-23-april-2022/): Haifa, Israel; Boston, MA – April 13, 2022 – MeMed, a leader in host response technologies, is pleased to announce that it will present their technology at the 32nd European Congress of Clinical Microbiology and Infectious Diseases Conference (ECCMID) in Lisbon, Portugal, April 23-26, 2022. Clinical key opinion leaders will present clinical use and performance data in
- [Fierce Medtech Names MeMed as One of its ‘Fierce 15’ Medical Technology Companies](https://memed-staging.freshy.dev/press_release/fierce-medtech-names-memed-as-one-of-its-fierce-15-medical-technology-companies/): Haifa, Israel; Boston, MA – March 7, 2022 – MeMed today announced that it has been named by Fierce Medtech as one of its ‘Fierce 15’ medical technology companies of 2021, designating it as one of the most promising private medtech companies in the industry. MeMed is a leader in the emerging field of advanced
- [MeMed Raises $93M to Accelerate Commercialization of its Host Immune-Response Product Portfolio](https://memed-staging.freshy.dev/press_release/memed-raises-93m-to-accelerate-commercialization-of-its-host-immune-response-product-portfolio/): MeMed BV® test recently cleared for use by US FDA to aid in distinguishing between bacterial and viral infection on the point-of-need platform MeMed Key® HAIFA, Israel; BOSTON, MA; January 10th, 2022 – MeMed, a leader in host response technologies, today announces a $93 million private financing round, bringing total funding in the Company to
- [Clinical Data Published in <i>Clinical Microbiology and Infection</i> Support Use of MeMed’s Test in Reducing Antibiotic Overuse in Children](https://memed-staging.freshy.dev/press_release/clinical-data-published-in-clinical-microbiology-and-infection-support-use-of-memeds-test-in-reducing-antibiotic-overuse-in-children/): The study demonstrated the test’s high performance in distinguishing between bacterial and viral infection Incorporated a broad pediatric population presenting with fever without source and respiratory tract infection MeMed’s test outperformed existing biomarkers of infection HAIFA, Israel, Boston, MA; December 1st, 2021 – MeMed, a leader in the emerging field of advanced host-response technologies, today
- [FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV Test and MeMed Key Platform](https://memed-staging.freshy.dev/press_release/fda-clears-first-technology-to-distinguish-between-bacterial-and-viral-infections-using-the-bodys-immune-response-the-memed-bv-test-and-memed-key-platform/): FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform MeMed BV is a first-of-its kind test that decodes the immune response to accurately distinguish between bacterial or viral infections within minutes MeMed Key is a pioneering platform that enables
- [MeMed Named a Finalist for AACC’s Disruptive Technology Award for MeMed COVID-19 Severity Test](https://memed-staging.freshy.dev/press_release/prospective-study-finds-potential-utility-of-memeds-host-immune-technology-for-personalizing-treatment-of-severe-covid-19-patients/): MeMed COVID-19 Severity reads the immune-system in real time to accurately determine whether SARS-Cov-2 patients are likely to have a severe outcome HAIFA, Israel, August 5th, 2021 – MeMed, a leader in host response-based technologies, announces today that it has been named a finalist for the American Association of Clinical Chemistry’s (AACC) Disruptive Technology Award for the
- [MeMed’s COVID-19 Severity Test Receives CE Mark for Predicting Severe Outcomes in COVID-19 Patients](https://memed-staging.freshy.dev/press_release/memeds-covid-19-severity-test-receives-ce-mark-for-predicting-severe-outcomes-in-covid-19-patients/): MeMed COVID-19 Severity reads the immune-system in real time to accurately determine whether SARS-Cov-2 patients are likely to have a severe outcome HAIFA, Israel; July 27th, 2021 – MeMed, a leader in host response-based technologies, today announces that it has received the CE Mark in Europe for its new disease management solution, MeMed COVID-19 Severity™. MeMed COVID-19
- [MeMed Key Wins Red Dot Award for High Design Quality](https://memed-staging.freshy.dev/press_release/memed-key-wins-red-dot-award-for-high-design-quality/): HAIFA, April 21, 2021- frog, a leading global design and strategy consultancy, part of Capgemini Invent, and MeMed, a pioneer in the field of host immune response technology are proud to announce that MeMed Key® has received the Red Dot Award for Product Design 2021. MeMed Key® is a cutting-edge technology platform that allows highly
- [Tanya Gottlieb, VP Scientific Affairs at MeMed, Appointed to the Board of the AMR Industry Alliance](https://memed-staging.freshy.dev/press_release/tanya-gottlieb-vp-scientific-affairs-at-memed-appointed-to-the-board-of-the-amr-industry-alliance/): HAIFA, Israel, April 19, 2021 – MeMed, a leader in advanced host-immune response technologies, is pleased to announce the appointment of Dr Tanya Gottlieb, VP Scientific Affairs at MeMed, to the Board of the AMR Industry Alliance (AMRIA). The AMR Industry Alliance is one of the largest private sector coalitions set up to provide sustainable
- [MeMed and 360Dx Bring Together International Experts for a Timely Discussion on Predicting COVID-19 Severity Using the Host Immune Response](https://memed-staging.freshy.dev/press_release/memed-and-360dx-bring-together-international-experts-for-a-timely-discussion-on-predicting-covid-19-severity-using-the-host-immune-response/): HAIFA, Israel, April 13, 2021 – MeMed, a leader in advanced host-immune response technologies, is pleased to be collaborating with 360Dx on a webinar entitled ‘Predicting COVID-19 Severity: Leveraging the Host Immune Response to Identify High-Risk Patients and Improve Outcomes.’ Published by GenomeWeb, 360Dx will host the 60-minute webinar on Monday, May 10th at 13.00
- [Riwat Lim Joins MeMed Team as Head of Commercial, Europe](https://memed-staging.freshy.dev/press_release/riwat-lim-joins-memed-team-as-head-of-commercial-europe/): Riwat brings to MeMed extensive commercial experience in the European life sciences industry HAIFA, Israel, January 18, 2021 – MeMed, a leader in advanced host-immune response technologies, today announces the appointment of Riwat Lim as Head of Commercial, Europe. Riwat is an experienced executive with a proven track record of commercial success and over 20
- [Troy Boutelle Joins MeMed as Vice President of Commercial in North America and General Manager, U.S.](https://memed-staging.freshy.dev/press_release/troy-boutelle-joins-memed-as-vice-president-of-commercial-in-north-america-and-general-manager-u-s/): Troy brings 20 years of top-flight sales and commercial experience as MeMed expands into the U.S. market HAIFA, Israel, January 12, 2021 – MeMed, a leader in Advanced Host-Immune Response Technologies, today announces the appointment of Troy Boutelle as Vice President of Commercial, North America and General Manager, US. Troy will spearhead MeMed’s operations in
- [MeMed Appoints Industry Veteran Chris Hibberd to its Board of Directors](https://memed-staging.freshy.dev/press_release/memed-appoints-industry-veteran-chris-hibberd-to-its-board-of-directors/): HAIFA, Israel, December 16, 2020 – MeMed, a leader in host immune response-based solutions, today announced that Chris Hibberd has joined its Board of Directors. Hibberd has more than 20 years of industry experience, leading global organizations that deliver high medical value products. “We’re delighted to welcome Chris Hibberd to our Board of Directors as
- [DiaSorin and MeMed Partner to Develop and Commercialize Novel Host Immune Response Based Diagnostics Solution](https://memed-staging.freshy.dev/press_release/diasorin-and-memed-partner-to-develop-and-commercialize-novel-host-immune-response-based-diagnostics-solution/): Licensing Agreement to add MeMed BV™, Immune System Based Protein Signature Test for Distinguishing Between Bacterial vs. Viral Infections, to the Broad DiaSorin LIAISONÒ Test Menu, Available on LIAISONÒ Analyzers SALUGGIA, Italy and HAIFA, Israel, September 8, 2020 - DiaSorin (FTSE MIB: DIA) and MeMed have announced today the creation of a strategic partnership to
- [MeMed’s COVID-19 Severity Test Receives CE Mark for Predicting Severe Outcomes in COVID-19 Patients](https://memed-staging.freshy.dev/press_release/memeds-covid-19-severity-test-receives-ce-mark-for-predicting-severe-outcomes-in-covid-19-patients-2/): COVID-19 Severity analyses host-immune response proteins to accurately determine whether patients infected with SARS-Cov-2 are likely to have a severe outcome HAIFA, Israel, July 23, 2021 – MeMed, a leader in host response-based solutions, today announces that it has received the CE Mark in Europe for its new disease management solution, MeMed COVID-19 Severity™. MeMed
- [MeMed Receives CE Mark for Two Pioneering Technologies: The MeMed BV Test and MeMed Key Point-of-Need Platform](https://memed-staging.freshy.dev/press_release/memed-receives-ce-mark-for-two-pioneering-technologies-the-memed-bv-test-and-memed-key-point-of-need-platform/): Cutting-edge instrument platform and a novel host-immune response signature test rapidly distinguish between viral and bacterial infections to improve patient outcomes HAIFA, Israel, June 2, 2020 – MeMed Ltd., a leader in host response-based solutions, today announced that it has received a CE Mark in Europe for use of its diagnostic test MeMed BV™ and
- [MeMed Advances Diagnostic Solutions for COVID-19 Pandemic to Enable Enhanced Patient Management](https://memed-staging.freshy.dev/press_release/memed-advances-diagnostic-solutions-for-covid-19-pandemic-to-enable-enhanced-patient-management/): Cutting-Edge Host Immune Response and Machine-Learning Technology Employed to Help Physicians Improve Risk Stratification, Diagnosis, Prognosis and Monitoring of Patients HAIFA, Israel, May 20, 2020 -- MeMed Ltd., a leader in host response-based diagnostic solutions, today announced that it is working on diagnostic solutions enabling enhanced patient management through risk stratification, monitoring and prognosis of
- [Diagnostics Industry Veteran Dr. Frédéric Sweeney Joins MeMed as Chief Business Development Officer](https://memed-staging.freshy.dev/press_release/diagnostics-industry-veteran-dr-frederic-sweeney-joins-memed-as-chief-business-development-officer/): HAIFA, Israel, Oct. 29, 2019 /PRNewswire/ -- MeMed Ltd., a leader in host response-based diagnostic solutions, today announced the addition of Dr. Frédéric Sweeney to its executive team as Chief Business Development Officer. Fred will focus on building strategic partnerships globally to accelerate market access of MeMed's technology suite, including MeMed BV™, the company's first-in-class,

## Videos

- [Surepoint Medical Center](https://memed-staging.freshy.dev/videos/surepoint-medical-center/): https://memed-staging.freshy.dev/wp-content/uploads/surepoint_er_v11-1080p.mp4
- [TrustCare Health](https://memed-staging.freshy.dev/videos/trustcare-health/): https://memed-staging.freshy.dev/wp-content/uploads/trust_healthcare-1080p.mp4
- [Physicians Premier ER](https://memed-staging.freshy.dev/videos/physicians-premier-er/): https://memed-staging.freshy.dev/wp-content/uploads/physicians_premier_er-2160p.mp4
- [MeMed BV Intro](https://memed-staging.freshy.dev/videos/memed-bv-intro/): https://memed-staging.freshy.dev/wp-content/uploads/MeMed-BV-Intro-Video-1.mp4
- [VIDEO: MeMed BV Training](https://memed-staging.freshy.dev/videos/video-memed-bv/): https://memed-staging.freshy.dev/wp-content/uploads/20240130-clinicians-training-video1.mp4
- [VIDEO: Calibrating MeMed Key for the MeMed Covid-19 Severity Test](https://memed-staging.freshy.dev/videos/video-calibrating-memed-keyc2ae-for-the-memed-covid-19-severity-test/): https://memed-staging.freshy.dev/wp-content/uploads/Calibrating-MeMed-KeyC2AE-for-the-MeMed-Covid-19-Severity-Test.mp4
- [VIDEO: Running external controls on the MeMed Key for the MeMed COVID-19 Severity Test](https://memed-staging.freshy.dev/videos/video-running-external-controls-on-the-memed-keyc2ae-for-the-memed-covid-19-severity-test/): https://memed-staging.freshy.dev/wp-content/uploads/Running-external-controls-on-the-MeMed-KeyC2AE-for-the-MeMed-Covid-19-Severity-Test.mp4
- [VIDEO ABSTRACT: Diagnostic Accuracy of a Real-Time Host-Protein Test for Infection](https://memed-staging.freshy.dev/videos/video-presentation-a-host-response-test-mmbv-for-differentiating-between-bacterial-and-viral-infection-has-the-potential-to-improve-antibiotic-stewardship-in-patients-with-suspected-sepsis-2/): https://memed-staging.freshy.dev/wp-content/uploads/Spirit-4-minute-video-abstract.mp4
- [VIDEO PRESENTATION: A Host Response Test (MMBV) for Differentiating Between Bacterial and Viral Infection has the Potential to Improve Antibiotic Stewardship in Patients With Suspected Sepsis](https://memed-staging.freshy.dev/videos/video-presentation-a-host-response-test-mmbv-for-differentiating-between-bacterial-and-viral-infection-has-the-potential-to-improve-antibiotic-stewardship-in-patients-with-suspected-sepsis/): https://memed-staging.freshy.dev/wp-content/uploads/ANGEL-MMBV-in-suspected-sepsis1.mp4
- [VIDEO: Real World Performance of MeMed BV at the 2023 AACC Annual Scientific Meeting](https://memed-staging.freshy.dev/videos/aacc-2023-memed-bv-industry-workshop/): Watch individual presentations.
- [WEBINAR: Bacterial or Viral from Research to Clinical use of MeMed BV in the Emergency Department](https://memed-staging.freshy.dev/videos/webinar-bacterial-or-viral-from-research-to-clinical-use-of-memed-bv-in-the-emergency/): https://memed-staging.freshy.dev/wp-content/uploads/Bacterial-or-viral-From-research-to-clinical-use-of-MeMed-BV-in-the-Emergency-Department.mp4
- [VIDEO: MeMed COVID-19 Severity Test](https://memed-staging.freshy.dev/videos/video-memed-covid-19-severity-test/): https://memed-staging.freshy.dev/wp-content/uploads/MeMed-COVID-19-Severity.mp4
- [VIDEO: How MeMed Technology Works](https://memed-staging.freshy.dev/videos/video-how-memed-technology-works/): https://memed-staging.freshy.dev/wp-content/uploads/MeMed_BV_MOA.mp4
- [WEBINAR: Differentiating Viral from Bacterial Infections with MeMed BV: Clinical Best](https://memed-staging.freshy.dev/videos/webinar-differentiating-viral-from-bacterial-infections-with-memed-bv-clinical-best/): https://memed-staging.freshy.dev/wp-content/uploads/Differentiating-Viral-from-Bacterial-Infections-with-MeMed-BV-Clinical-Best-Practices-Case-Studies-and-Insights.mp4
- [VIDEO: This Medical Startup Does the Impossible!](https://memed-staging.freshy.dev/videos/video-this-medical-startup-does-the-impossible/)
- [VIDEO: MeMed BV on MeMed Key](https://memed-staging.freshy.dev/videos/video-memed-bv-on-memed-key/): https://memed-staging.freshy.dev/wp-content/uploads/MeMed_Web_Video-low-res.mp4
- [VIDEO PRESENTATION: A Rapidly Measurable Host Assay Comprising TRAIL, IP-10 and CRP Has Potential to Reduce Antibiotic Overuse without Increasing Underuse in Adults With Suspected Lower Respiratory Tract Infection, CDiff Foundation 2021](https://memed-staging.freshy.dev/videos/video-presentation-a-rapidly-measurable-host-assay-comprising-trail-ip-10-and-crp-has-potential-to-reduce-antibiotic-overuse-without-increasing-underuse-in-adults-with-suspected-lower-respiratory-tr/): https://memed-staging.freshy.dev/wp-content/uploads/CDIFF21.mp4
- [VIDEO PRESENTATION: Disruptive Technology Award, AACC 2021](https://memed-staging.freshy.dev/videos/video-presentation-disruptive-technology-award-aacc-2021/): https://memed-staging.freshy.dev/wp-content/uploads/2021-AACC-Disruptive-Technology-Award-Finalist.mp4
- [VIDEO PRESENTATION: Is it a Bacterial or Viral Infection? Using Host-Response](https://memed-staging.freshy.dev/videos/video-presentation-is-it-a-bacterial-or-viral-infection-using-host-response-2/): https://memed-staging.freshy.dev/wp-content/uploads/2021-09-28-Theater-2-Main-Session-5-MeMed-720p-2.mp4
- [VIDEO PRESENTATION: Host-response Technology can Improve Antibiotic Treatment](https://memed-staging.freshy.dev/videos/video-presentation-host-response-technology-can-improve-antibiotic-treatment/): https://memed-staging.freshy.dev/wp-content/uploads/MeMed-CEO-Co-founder-Dr.-Eran-Eden-lectures-@-ECCMID-2021.mp4
- [VIDEO PRESENTATION: A Host-based Assay Comprising TRAIL, IP-10 and CRP](https://memed-staging.freshy.dev/videos/video-presentation-a-host-based-assay-comprising-trail-ip-10-and-crp/): https://memed-staging.freshy.dev/wp-content/uploads/Prof.-Susanna-Esposito-lectures-@-ECCMID-2021.mp4

## Webinars

- [WEBINAR: The Case for MeMed BV: Antimicrobial Resistance and Antimicrobial Stewardship](https://memed-staging.freshy.dev/webinars/webinar-the-case-for-memed-bv-antimicrobial-resistance-and-antimicrobial/): https://memed-staging.freshy.dev/wp-content/uploads/Kevin-Garey-Webinar.mp4
- [WEBINAR: Bacterial or Viral from Research to Clinical use of MeMed BV in the Emergency](https://memed-staging.freshy.dev/webinars/webinar-bacterial-or-viral-from-research-to-clinical-use-of-memed-bv-in-the-emergency/): https://memed-staging.freshy.dev/wp-content/uploads/Bacterial-or-viral-From-research-to-clinical-use-of-MeMed-BV-in-the-Emergency-Department.mp4
- [WEBINAR: Differentiating Viral from Bacterial Infections with MeMed BV: Clinical Best](https://memed-staging.freshy.dev/webinars/webinar-differentiating-viral-from-bacterial-infections-with-memed-bv-clinical-best/): https://memed-staging.freshy.dev/wp-content/uploads/Differentiating-Viral-from-Bacterial-Infections-with-MeMed-BV-Clinical-Best-Practices-Case-Studies-and-Insights.mp4

## Key 1.2 Videos

- [MeMed Key® Download Failure Logs 1.2](https://memed-staging.freshy.dev/key_1_2_videos/memed-key-download-failure-logs-1-2/): /wp-content/uploads/VD13002-MeMed-Key®-Download-Failure-Logs-V2.0.0.mp4
- [Unpacking and Installation of the MeMed Key™ 1.2](https://memed-staging.freshy.dev/key_1_2_videos/unpacking-and-installation-of-the-memed-key-1-2/): /wp-content/uploads/Unpacking-and-Installation-of-the-MeMed-Key®.mp4
- [Running External Control 1.2](https://memed-staging.freshy.dev/key_1_2_videos/running-external-control-1-2/): /wp-content/uploads/VD12001-Running-External-Control-V2.0.0.sm_.mp4
- [Calibrating MeMed Key® for the MeMed BV® Test 1.2](https://memed-staging.freshy.dev/key_1_2_videos/calibrating-memed-key-for-the-memed-bv-test-1-2/): /wp-content/uploads/VD11001-Calibrating-MeMed-Key®-for-the-MeMed-BV®-Test-V2.0.0.sm_-1.mp4
- [Running the MeMed BV® Test](https://memed-staging.freshy.dev/key_1_2_videos/running-the-memed-bv-test/): /wp-content/uploads/VD10001-Running-the-MeMed-BV®-Test-V2.0.0-1.mp4
- [MeMed BV® Cartridge Storage 1.2](https://memed-staging.freshy.dev/key_1_2_videos/memed-bv-cartridge-storage-1-2/): /wp-content/uploads/VD10002-MeMed-BV®-Cartridge-Storage-V2.0.0-1.mp4

## Learning Center Posts

- [ABSTRACT: TRAIL, IP-10, CRP Host-protein Signature Score Distinguishes Between Viral And Bacterial Infection In Sepsis Patients](https://memed-staging.freshy.dev/learning_center/abstract-trail-ip-10-crp-host-protein-signature-score-distinguishes-between-viral-and-bacterial-infection-in-sepsis-patients/)
- [Poster: Implementation of a Host-Protein Test (MMBV) Into Routine Care for Children Hospitalized with Symptoms of Lower Respiratory Tract Infection](https://memed-staging.freshy.dev/wp-content/uploads/2235_IDWPOSTER.pdf)
- [Abstract: Using a Host-Protein Test (Based on TRAIL/IP-10/CRP) to Assess the Likelihood of Bacterial Infection in Patients with Suspected Sepsis](https://memed-staging.freshy.dev/learning_center/abstract-using-a-host-protein-test-based-on-trail-ip-10-crp-to-assess-the-likelihood-of-bacterial-infection-in-patients-with-suspected-sepsis/)
- [Surepoint Medical Center](https://memed-staging.freshy.dev/learning_center/surepoint-medical-center/)
- [TrustCare Health](https://memed-staging.freshy.dev/learning_center/trustcare-health/)
- [Physicians Premier ER](https://memed-staging.freshy.dev/learning_center/physicians-premier-er/)
- [Abstract: Pilot Evaluation of a Host-Protein Test in Emergency Department Patients Who Trigger a Sepsis Alert](https://memed-staging.freshy.dev/learning_center/pilot-evaluation-of-a-host-protein-test-in-emergency-department-patients-who-trigger-a-sepsis-alert/)
- [Abstract: Differentiating Bacterial Versus Viral Infections in Elderly Patients With Suspected UTI: A Pilot Study](https://memed-staging.freshy.dev/learning_center/abstract-differentiating-bacterial-versus-viral-infections-in-elderly-patients-with-suspected-uti-a-pilot-study/)
- [Abstract: Impact of a Host-Protein Test on Antibiotic Use and Healthcare Costs in LRTI: JUNO RCT Sub-Analysis](https://memed-staging.freshy.dev/learning_center/abstract-impact-of-a-host-protein-test-on-antibiotic-use-and-healthcare-costs-in-lrti-juno-rct-sub-analysis/)
- [Abstract: Host-Protein Test in Routine Emergency Department Practice: Impact on Antibiotic Prescription, Admission, and Emergency Department Return](https://memed-staging.freshy.dev/learning_center/abstract-pilot-evaluation-of-a-host-protein-test-in-emergency-department-patients-who-trigger-a-sepsis-alert/)
- [Abstract: A Novel Host-Response Tool for Risk Stratification in Adults With Suspected Sepsis: MeMed Severity](https://memed-staging.freshy.dev/learning_center/a-novel-host-response-tool-for-risk-stratification-in-adults-with-suspected-sepsis-memed-severity/)
- [Diagnostic Insights: Triverity vs. MeMed BV](https://memed-staging.freshy.dev/learning_center/diagnostic-insights-triverity-vs-memed-bv/)
- [VIDEO PRESENTATION: Is it a Bacterial or Viral Infection? Using Host Response Technologies to Decode the Immune System and Aid Antibiotic Stewardship](https://memed-staging.freshy.dev/learning_center/video-presentation-is-it-a-bacterial-or-viral-infection-using-host-response-technologies-to-decode-the-immune-system-and-aid-antibiotic-stewardship/)
- [Diagnostic Insights: Pneumonia, Precision and Pounds: The Economic Power of Accurate Diagnosis with MeMed BV](https://memed-staging.freshy.dev/learning_center/diagnostic-insights-pneumonia-precision-and-pounds-the-economic-power-of-accurate-diagnosis-with-memed-bv/)
- [Diagnostic Insights: Lessons from the Juno Trial](https://memed-staging.freshy.dev/learning_center/diagnostic-insights-lessons-from-the-juno-trial/)
- [Effect of Host- Protein Test (TRAIL/IP- 10/CRP) on Antibiotic Prescription and Emergency Department or Urgent Care Center Return Visits: The JUNO Pilot Randomized Controlled Trial](https://memed-staging.freshy.dev/learning_center/effect-of-host-protein-test-trail-ip-10-crp-on-antibiotic-prescription-and-emergency-department-or-urgent-care-center-return-visits-the-juno-pilot-randomized-controlled-trial/)
- [From Pathogen to Infectious Disease Diagnosis: Test Determines Between Bacterial and Viral Infections in 15 Minutes](https://memed-staging.freshy.dev/learning_center/from-pathogen-to-infectious-disease-diagnosis-test-determines-between-bacterial-and-viral-infections-in-15-minutes/)
- [Host-response testing with MeMed BV in Community-Acquired Pneumonia: An Economic Evaluation From the UK NHS Perspective](https://academic.oup.com/jacamr/article/7/1/dlaf016/8023371?searchresult=1&#038;login=false)
- [Development of a Reference Standard to Assign Bacterial Versus Viral Infection Etiology Using an All-Inclusive Methodology for Comparison of Novel Diagnostic Tool Performance](https://memed-staging.freshy.dev/learning_center/development-of-a-reference-standard-to-assign-bacterial-versus-viral-infection-etiology-using-an-all-inclusive-methodology-for-comparison-of-novel-diagnostic-tool-performance/)
- [Implementation of a Rapid Host-Protein Diagnostic Test for Distinguishing Bacterial and Viral Infections in Adults Presenting to Urgent Care Centers: A Pragmatic Cohort Study](https://memed-staging.freshy.dev/learning_center/implementation-of-a-rapid-host-protein-diagnostic-test-for-distinguishing-bacterial-and-viral-infections-in-adults-presenting-to-urgent-care-centers-a-pragmatic-cohort-study/)
- [MeMed BV Intro](https://memed-staging.freshy.dev/learning_center/memed-bv-intro/)
- [VIDEO: MeMed BV Training](https://memed-staging.freshy.dev/learning_center/memed-bv-training-video/)
- [Poster: Diagnostic Performance of a Rapid Host-Protein Test (MeMed BV) In Detecting Bacteremia in Children](https://memed-staging.freshy.dev/learning_center/poster-diagnostic-performance-of-a-rapid-host-protein-test-memed-bv-in-detecting-bacteremia-in-children/)
- [Abstract: Host-Protein Test Impact on Antibiotic Prescription Rates in Adults With Suspected Lower Respiratory Tract Infection](https://memed-staging.freshy.dev/learning_center/abstract-host-protein-test-impact-on-antibiotic-prescription-rates-in-adults-with-suspected-lower-respiratory-tract-infection/)
- [Abstract: Real World Experience Using a Rapid Test to Distinguish Bacterial From Viral Infection in the Emergency Department](https://memed-staging.freshy.dev/learning_center/abstract-real-world-experience-using-a-rapid-test-to-distinguish-bacterial-from-viral-infection-in-the-emergency-department/)
- [Abstract: Verification and Validation Study for a Host Response Assay Based on TRAIL, IP-10, and CRP: Application to Pediatric Emergency Department](https://memed-staging.freshy.dev/learning_center/abstract-verification-and-validation-study-for-a-host-response-assay-based-on-trail-ip-10-and-crp-application-to-pediatric-emergency-department/)
- [Abstract: A Rapid Host-Response Test Supports Antimicrobial Stewardship at a Micro-Hospital Emergency Department](https://memed-staging.freshy.dev/learning_center/abstract-a-rapid-host-response-test-supports-antimicrobial-stewardship-at-a-micro-hospital-emergency-department/)
- [Abstract: The Association of the MeMed BV Test with Radiographic Pneumonia in Children](https://memed-staging.freshy.dev/learning_center/abstract-the-association-of-the-memed-bv-test-with-radiographic-pneumonia-in-children/)
- [Abstract: Impact of a Novel Host-Response Diagnostic on ED Antibiotic Decision-Making](https://memed-staging.freshy.dev/learning_center/impact-of-a-novel-host-response-diagnostic-on-ed-antibiotic-decision-making/)
- [ABSTRACT: Diagnostic Test Accuracy of TRAIL, IP-10 and C-RP Biomarker Combination (MeMed BV Test) for Discrimination of Viral vs. Bacterial Infections Among Emergency Department Patients with Febrile Illness: A Systematic Review and Meta-Analysis](https://memed-staging.freshy.dev/learning_center/abstract-diagnostic-test-accuracy-of-trail-ip-10-and-c-rp-biomarker-combination-memed-bv-test-for-discrimination-of-viral-vs-bacterial-infections-among-emergency-department-patients-with-febrile/)
- [ABSTRACT: An Adjunct Bio-Array that Rapidly Differentiates Viral from Bacterial Sources Can Improve Quality of Care in Oncology Patients Presenting to Emergency Departments (EDs) with Respiratory Illnesses](https://memed-staging.freshy.dev/learning_center/abstract-an-adjunct-bio-array-that-rapidly-differentiates-viral-from-bacterial-sources-can-improve-quality-of-care-in-oncology-patients-presenting-to-emergency-departments-eds-with-respiratory-illn/)
- [PUBLICATION: Assessment of MeMed BV Assays for Differentiating Between Bacterial and Viral Respiratory Infections](https://memed-staging.freshy.dev/learning_center/assessment-of-memed-bv-assays-for-differentiating-between-bacterial-and-viral-respiratory-infections/)
- [PUBLICATION: Chapter 10 - Infection and Inflammation: A Double-Edged Sword](https://memed-staging.freshy.dev/learning_center/publication-chapter-10-infection-and-inflammation-a-double-edged-sword/)
- [Abstract: Bacterial Versus Viral Score Test: Evaluating Potential for Antibiotic Stewardship in Pediatrics](https://memed-staging.freshy.dev/learning_center/bacterial-versus-viral-score-test-evaluating-potential-for-antibiotic-stewardship-in-pediatrics/)
- [Abstract: Real - World Impact of MeMed BV, a Rapid Host Response Test for Distinguishing Bacterial and Viral Infections, in an Urgent Care Network](https://memed-staging.freshy.dev/learning_center/abstract-real-world-impact-of-memed-bv-a-rapid-host-response-test-for-distinguishing-bacterial-and-viral-infections-in-an-urgent-care-network/)
- [PUBLICATION: A Rapid Host–Protein Test for Differentiating Bacterial from Viral Infection: Apollo Diagnostic Accuracy Study](https://memed-staging.freshy.dev/learning_center/publication-a-rapid-host-protein-test-for-differentiating-bacterial-from-viral-infection-apollo-diagnostic-accuracy-study/)
- [PUBLICATION: Validation of a Whole Blood Machine Learning Strategy for Distinguishing Between Bacterial and Viral Infection in a Pediatric Hospital Setting](https://memed-staging.freshy.dev/learning_center/publication-validation-of-a-whole-blood-machine-learning-strategy-for-distinguishing-between-bacterial-and-viral-infection-in-a-pediatric-hospital-setting/)
- [ABSTRACT: Real-World Impact of a Novel Host Response Test for Distinguishing Between Bacterial and Viral Infections in Pediatric Patients at Ten Urgent Care Centers](https://memed-staging.freshy.dev/learning_center/publication-real-world-impact-of-a-novel-host-response-test-for-distinguishing-between-bacterial-and-viral-infections-in-pediatric-patients-at-ten-urgent-care-centers/)
- [PUBLICATION: Natural Variability of TRAIL, IP-10, and CRP in Healthy Adults – The “HERACLES” Study](https://memed-staging.freshy.dev/learning_center/publication-natural-variability-of-trail-ip-10-and-crp-in-healthy-adults-the-heracles-study/)
- [PUBLICATION: Host Biomarkers and Combinatorial Scores for the Detection of Serious and Invasive Bacterial Infection in Pediatric Patients with Fever Without Source](https://memed-staging.freshy.dev/learning_center/publication-host-biomarkers-and-combinatorial-scores-for-the-detection-of-serious-and-invasive-bacterial-infection-in-pediatric-patients-with-fever-without-source/)
- [PUBLICATION: Antibiotic Misuse In Respiratory Tract Infections in Children And Adults—A Prospective, Multicentre Study (TAILORED Treatment)](https://memed-staging.freshy.dev/learning_center/publication-antibiotic-misuse-in-respiratory-tract-infections-in-children-and-adults-a-prospective-multicentre-study-tailored-treatment/)
- [PUBLICATION: MeMed BV Testing in Emergency Department Patients Presenting With Febrile Illness Concerning for Respiratory Tract Infection](https://memed-staging.freshy.dev/learning_center/publication-memed-bv-testing-in-emergency-department-patients-presenting-with-febrile-illness-concerning-for-respiratory-tract-infection/)
- [PUBLICATION: Expression of TRAIL, IP-10, and CRP in Children With Suspected COVID-19 and Real-life Impact of a Computational Signature on Clinical Decision-making: A Prospective Cohort Study](https://memed-staging.freshy.dev/learning_center/publication-expression-of-trail-ip-10-and-crp-in-children-with-suspected-covid-19-and-real-life-impact-of-a-computational-signature-on-clinical-decision-making-a-prospective-cohort-study/)
- [PUBLICATION: An Immune-protein Signature Combining TRAIL, IP-10 and CRP for Accurate Prediction of Severe COVID-19 Outcome](https://memed-staging.freshy.dev/learning_center/publication-an-immune-protein-signature-combining-trail-ip-10-and-crp-for-accurate-prediction-of-severe-covid-19-outcome/)
- [PUBLICATION: Assessing the Febrile Child for Serious Infection: A Step Closer to Meaningful Rapid Results](https://memed-staging.freshy.dev/learning_center/publication-assessing-the-febrile-child-for-serious-infection-a-step-closer-to-meaningful-rapid-results/)
- [PUBLICATION: A Novel Host-Proteome Signature for Distinguishing between Acute Bacterial and Viral Infections](https://memed-staging.freshy.dev/learning_center/publication-a-novel-host-proteome-signature-for-distinguishing-between-acute-bacterial-and-viral-infections/)
- [PUBLICATION: A Multifaceted ‘omics’ Approach for Addressing the Challenge of Antimicrobial Resistance](https://memed-staging.freshy.dev/learning_center/publication-a-multifaceted-omics-approach-for-addressing-the-challenge-of-antimicrobial-resistance/)
- [PUBLICATION: Diagnostic Accuracy of a TRAIL, IP-10 and CRP Combination for Discriminating Bacterial and Viral Etiologies at the Emergency Department](https://memed-staging.freshy.dev/learning_center/publication-diagnostic-accuracy-of-a-trail-ip-10-and-crp-combination-for-discriminating-bacterial-and-viral-etiologies-at-the-emergency-department/)
- [PUBLICATION: A Host-protein Based Assay to Differentiate Between Bacterial and Viral Infections in Preschool Children (Opportunity): A Double-blind, Multicentre, Validation Study](https://memed-staging.freshy.dev/learning_center/publication-a-host-protein-based-assay-to-differentiate-between-bacterial-and-viral-infections-in-preschool-children-opportunity-a-double-blind-multicentre-validation-study/)
- [PUBLICATION: A Novel Host-protein Assay Outperforms Routine Parameters for Distinguishing Between Bacterial and Viral Lower Respiratory Tract Infections](https://memed-staging.freshy.dev/learning_center/publication-a-novel-host-protein-assay-outperforms-routine-parameters-for-distinguishing-between-bacterial-and-viral-lower-respiratory-tract-infections/)
- [PUBLICATION: Automating a New Host-protein Assay for Differentiating Bacterial From Viral Infection to Reduce Operator Hands-on Time](https://memed-staging.freshy.dev/learning_center/publication-automating-a-new-host-protein-assay-for-differentiating-bacterial-from-viral-infection-to-reduce-operator-hands-on-time/)
- [PUBLICATION: Update of a Clinical Prediction Model for Serious Bacterial Infections in Preschool Children by Adding a Host-protein-based Assay: A Diagnostic Study](https://memed-staging.freshy.dev/learning_center/publication-update-of-a-clinical-prediction-model-for-serious-bacterial-infections-in-preschool-children-by-adding-a-host-protein-based-assay-a-diagnostic-study/)
- [PUBLICATION: A Host-Response Signature Based on TRAIL, IP-10 and CRP Addresses Antibiotic Misuse Driven by Diagnostic Uncertainty](https://memed-staging.freshy.dev/learning_center/publication-a-host-response-signature-based-on-trail-ip-10-and-crp-addresses-antibiotic-misuse-driven-by-diagnostic-uncertainty/)
- [PUBLICATION: Observational Cohort Study of IP-10’s Potential as a Biomarker to aid in Inflammation Regulation Within a Clinical Decision Support Protocol for Patients With Severe COVID-19](https://memed-staging.freshy.dev/learning_center/publication-observational-cohort-study-of-ip-10s-potential-as-a-biomarker-to-aid-in-inflammation-regulation-within-a-clinical-decision-support-protocol-for-patients-with-severe-covid-19/)
- [PUBLICATION: Distinguishing Bacterial Versus Non-bacterial Causes of Febrile Illness – A Systematic Review of Host Biomarkers](https://memed-staging.freshy.dev/learning_center/publication-distinguishing-bacterial-versus-non-bacterial-causes-of-febrile-illness-a-systematic-review-of-host-biomarkers/)
- [PUBLICATION: Cost Impact Analysis of Novel Host-response Diagnostic for Patients With Community-acquired Pneumonia in the Emergency Department](https://memed-staging.freshy.dev/learning_center/publication-cost-impact-analysis-of-novel-host-response-diagnostic-for-patients-with-community-acquired-pneumonia-in-the-emergency-department/)
- [PUBLICATION: Differential Serum and Urine CRP, IP-10, and TRAIL Levels in Pediatric Urinary Tract Infection](https://memed-staging.freshy.dev/learning_center/publication-differential-serum-and-urine-crp-ip-10-and-trail-levels-in-pediatric-urinary-tract-infection/)
- [PUBLICATION: A Point-of-need Platform for Rapid Measurement of A Host-protein Score That Differentiates Bacterial From Viral Infection: Analytical Evaluation](https://memed-staging.freshy.dev/learning_center/publication-a-point-of-need-platform-for-rapid-measurement-of-a-host-protein-score-that-differentiates-bacterial-from-viral-infection-analytical-evaluation/)
- [PUBLICATION: A Host Signature Based on TRAIL, IP-10, and CRP for Reducing Antibiotic Overuse in Children by Differentiating Bacterial From Viral Infections: A Prospective, Multicentre Cohort Study](https://memed-staging.freshy.dev/learning_center/publication-a-host-signature-based-on-trail-ip-10-and-crp-for-reducing-antibiotic-overuse-in-children-by-differentiating-bacterial-from-viral-infections-a-prospective-multicentre-cohort-study/)
- [PUBLICATION: TRAIL, IP-10, CRP Host-protein Signature Score Distinguishes Between Viral and Bacterial Infection in Sepsis Patients](https://memed-staging.freshy.dev/learning_center/publication-o02-trail-ip-10-crp-host-protein-signature-score-distinguishes-between-viral-and-bacterial-infection-in-sepsis-patients/)
- [PUBLICATION: BV Score Differentiates Viral From Bacterial-viral Co-infection in Adenovirus PCR Positive Children](https://memed-staging.freshy.dev/learning_center/publication-bv-score-differentiates-viral-from-bacterial-viral-co-infection-in-adenovirus-pcr-positive-children/)
- [PUBLICATION: Bacterial vs. Viral Etiology of Fever: A Prospective Study of a Host Score for Supporting Etiologic Accuracy of Emergency Department Physicians](https://memed-staging.freshy.dev/learning_center/publication-bacterial-vs-viral-etiology-of-fever-a-prospective-study-of-a-host-score-for-supporting-etiologic-accuracy-of-emergency-department-physicians/)
- [PUBLICATION: Diagnostic Accuracy of a Real-Time Host-Protein Test for Infection](https://memed-staging.freshy.dev/learning_center/publication-diagnostic-accuracy-of-a-real-time-host-protein-test-for-infection/)
- [VIDEO ABSTRACT: Diagnostic Accuracy of a Real-Time Host-Protein Test for Infection](https://memed-staging.freshy.dev/learning_center/video-abstract-diagnostic-accuracy-of-a-real-time-host-protein-test-for-infection/)
- [VIDEO PRESENTATION: A Host Response Test (MMBV) for Differentiating Between Bacterial and Viral Infection has the Potential to Improve Antibiotic Stewardship in Patients With Suspected Sepsis](https://memed-staging.freshy.dev/learning_center/video-presentation-a-host-response-test-mmbv-for-differentiating-between-bacterial-and-viral-infection-has-the-potential-to-improve-antibiotic-stewardship-in-patients-with-suspected-sepsis/)
- [VIDEO PRESENTATION: A Rapidly Measurable Host Assay Comprising TRAIL, IP-10 And CRP has Potential to Reduce Antibiotic Overuse Without Increasing Underuse in Adults With Suspected Lower Respiratory Tract Infection](https://memed-staging.freshy.dev/learning_center/video-presentation-a-rapidly-measurable-host-assay-comprising-trail-ip-10-and-crp-has-potential-to-reduce-antibiotic-overuse-without-increasing-underuse-in-adults-with-suspected-lower-respiratory-tr/)
- [VIDEO PRESENTATION: A Host-based Assay Comprising TRAIL, IP-10 and CRP Outperforms Procalcitonin in Accurately Distinguishing Between Bacterial and Viral Infection in Febrile Children](https://memed-staging.freshy.dev/learning_center/video-presentation-a-host-based-assay-comprising-trail-ip-10-and-crp-outperforms-procalcitonin-in-accurately-distinguishing-between-bacterial-and-viral-infection-in-febrile-children/)
- [VIDEO PRESENTATION: Disruptive Technology Award, AACC 2021](https://memed-staging.freshy.dev/learning_center/video-presentation-disruptive-technology-award-aacc-2021/)
- [ABSTRACT: Validation of a multi analyte immunoassay for distinguishing bacterial vs. viral infections in a pediatric cohort](https://memed-staging.freshy.dev/learning_center/abstract-validation-of-a-multi-analyte-immunoassay-for-distinguishing-bacterial-vs-viral-infections-in-a-pediatric-cohort/)
- [ABSTRACT: Analytical validation of whole blood suitability for MeMed BV, a host-protein test for differentiating between bacterial and viral infection](https://memed-staging.freshy.dev/learning_center/abstract-analytical-validation-of-whole-blood-suitability-for-memed-bv-a-host-protein-test-for-differentiating-between-bacterial-and-viral-infection/)
- [ABSTRACT: Comparison between blood culture and MeMed BV test results](https://memed-staging.freshy.dev/learning_center/abstract-comparison-between-blood-culture-and-memed-bv-test-results/)
- [WEBINAR: Bacterial or Viral from Research to Clinical use of MeMed BV in the Emergency Department](https://memed-staging.freshy.dev/learning_center/webinar-bacterial-or-viral-from-research-to-clinical-use-of-memed-bv-in-the-emergency-department/)
- [VIDEO: Real World Performance of MeMed BV Workshop at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo](https://memed-staging.freshy.dev/learning_center/real-world-performance-of-memed-bv-workshop-at-the-2023-aacc-annual-scientific-meeting-clinical-lab-expo/)
- [ABSTRACT: A host protein test based on TRAIL, IP-10 and CRP for differentiating between bacterial and viral infection has potential to improve patient selection for blood culture utilization](https://memed-staging.freshy.dev/learning_center/abstract-a-host-protein-test-based-on-trail-ip-10-and-crp-for-differentiating-between-bacterial-and-viral-infection-has-potential-to-improve-patient-selection-for-blood-culture-utilization/)
- [ABSTRACT: Using MeMed BV® to reduce antibiotic us for low-risk CAP](https://memed-staging.freshy.dev/learning_center/abstract-using-memed-bv-to-reduce-antibiotic-us-for-low-risk-cap/)
- [PUBLICATION: Host Test Based on TRAIL, IP-10 and CRP for Differentiating Bacterial and Viral Respiratory Tract Infections in Adults: Diagnostic Accuracy Study](https://memed-staging.freshy.dev/learning_center/publication-validation-of-a-multi-analyte-immunoassay-for-distinguishing-bacterial-vs-viral-infections-in-a-pediatric-cohort/)
- [PUBLICATION: Validation of a Multi-Analyte Immunoassay for Distinguishing Bacterial vs. Viral Infections in a Pediatric Cohort](https://memed-staging.freshy.dev/learning_center/shirley/)
- [PUBLICATION: Impact on Patient Management of a Novel Host Response Test for Distinguishing Bacterial and Viral Infections: Real World Evidence from the Urgent Care Setting](https://memed-staging.freshy.dev/learning_center/publication-impact-on-patient-management-of-a-novel-host-response-test-for-distinguishing-bacterial-and-viral-infections-real-world-evidence-from-the-urgent-care-setting/)
- [ABSTRACT: A new test, based on the measure of three non microbial host proteins, for the differentiation between bacterial and viral infections](https://memed-staging.freshy.dev/learning_center/5132/)
- [ABSTRACT: Clinical impact of a near patient assay capable of discriminating between viral or bacterial lower respiratory tract infection in ambulatory adult patients a pilot study](https://memed-staging.freshy.dev/learning_center/abstract-clinical-impact-of-a-near-patient-assay-capable-of-discriminating-between-viral-or-bacterial-lower-respiratory-tract-infection-in-ambulatory-adult-patients-a-pilot-study/)
- [WEBINAR: The Case for MeMed BV: Antimicrobial Resistance and Antimicrobial](https://memed-staging.freshy.dev/learning_center/webinar-the-case-for-memed-bv-antimicrobial-resistance-and-antimicrobial/)
- [WEBINAR: Differentiating Viral from Bacterial Infections with MeMed BV: Clinical Best](https://memed-staging.freshy.dev/learning_center/webinar-differentiating-viral-from-bacterial-infections-with-memed-bv-clinical-best/)
- [VIDEO PRESENTATION: Host-response Technology can Improve Antibiotic Treatment](https://memed-staging.freshy.dev/learning_center/video-presentation-host-response-technology-can-improve-antibiotic-treatment/)
- [VIDEO PRESENTATION: A Host-based Assay Comprising TRAIL, IP-10 and CRP](https://memed-staging.freshy.dev/learning_center/video-presentation-a-host-based-assay-comprising-trail-ip-10-and-crp/)
- [VIDEO PRESENTATION: Disruptive Technology Award, AACC 2021](https://memed-staging.freshy.dev/learning_center/video-presentation-disruptive-technology-award-aacc-2021-2/)
- [VIDEO: How MeMed Technology Works](https://memed-staging.freshy.dev/learning_center/video-how-memed-technology-works/)
- [VIDEO: This Medical Startup Does the Impossible!](https://memed-staging.freshy.dev/learning_center/video-this-medical-startup-does-the-impossible/)
- [VIDEO: MeMed BV on MeMed Key](https://memed-staging.freshy.dev/learning_center/video-memed-bv-on-memed-key/)
- [VIDEO PRESENTATION: A Rapidly Measurable Host Assay Comprising TRAIL, IP-10 and CRP Has Potential to Reduce Antibiotic Overuse without Increasing Underuse in Adults With Suspected Lower Respiratory Tract Infection, CDiff Foundation 2021](https://memed-staging.freshy.dev/learning_center/video-presentation-a-rapidly-measurable-host-assay-comprising-trail-ip-10-and-crp-has-potential-to-reduce-antibiotic-overuse-without-increasing-underuse-in-adults-with-suspected-lower-respiratory-tr-2/)
- [WEBINAR: Differentiating Viral from Bacterial Infections with MeMed BV: Clinical Best](https://memed-staging.freshy.dev/learning_center/webinar-differentiating-viral-from-bacterial-infections-with-memed-bv-clinical-best-2/)
- [ABSTRACT: MeMed BV Distinguishes Between Viral And Bacterial Infection In Sepsis Patients](https://memed-staging.freshy.dev/learning_center/abstract-memed-bv-distinguishes-between-viral-and-bacterial-infection-in-sepsis-patients/)
- [ABSTRACT: Host-Protein Score (Integrating TRAIL, IP-10, CRP) Distinguishes Between Viral and Viral-Bacterial Co-infection in Adult Patients Testing Positive for Viral Detection](https://memed-staging.freshy.dev/learning_center/abstract-host-protein-score-integrating-trail-ip-10-crp-distinguishes-between-viral-and-viral-bacterial-co-infection-in-adult-patients-testing-positive-for-viral-detection/)
- [ABSTRACT: A Host-based Assay Comprising TRAIL, IP10, and CRP Can Improve Antibiotic Treatment Decisions For Viral PCR Positive Children By Accurately Ruling Out Co-infection](https://memed-staging.freshy.dev/learning_center/abstract-a-host-based-assay-comprising-trail-ip10-and-crp-can-improve-antibiotic-treatment-decisions-for-viral-pcr-positive-children-by-accurately-ruling-out-co-infection/)
- [ABSTRACT: A Rapidly Measurable Host Assay Comprising TRAIL, IP-10 AND CRP Has Potential To Reduce Antibiotic Overuse Without Increasing Underuse In Adults With Suspected Lower Respiratory Tract Infection](https://memed-staging.freshy.dev/learning_center/abstract-a-rapidly-measurable-host-assay-comprising-trail-ip-10-and-crp-has-potential-to-reduce-antibiotic-overuse-without-increasing-underuse-in-adults-with-suspected-lower-respiratory-tract-infect/)
- [ABSTRACT: Leveraging The Immune Response To Improve Outbreak Management: Derivation Of A Rapidly Measurable Host-protein Signature For Stratifying Severity Of COVID-19 Patients](https://memed-staging.freshy.dev/learning_center/abstract-leveraging-the-immune-response-to-improve-outbreak-management-derivation-of-a-rapidly-measurable-host-protein-signature-for-stratifying-severity-of-covid-19-patients/)
- [ABSTRACT: Validation Of A Novel Semi-quantitative Immunoassay To Differentiate Bacterial Vs Viral Infections From Serum Samples](https://memed-staging.freshy.dev/learning_center/abstract-validation-of-a-novel-semi-quantitative-immunoassay-to-differentiate-bacterial-vs-viral-infections-from-serum-samples/)
- [ABSTRACT: MeMed BV Distinguishes Between Viral And Bacterial Infection In Sepsis Patients](https://memed-staging.freshy.dev/learning_center/abstract-memed-bv-distinguishes-between-viral-and-bacterial-infection-in-sepsis-patients-2/)
- [ABSTRACT: BV Score’s Performance When Applied According To Indications For Use As Part Of Routine Care For Children Presenting To The Ed With Fever Without Source (Spirit Study Sub Analysis)](https://memed-staging.freshy.dev/learning_center/abstract-bv-scores-performance-when-applied-according-to-indications-for-use-as-part-of-routine-care-for-children-presenting-to-the-ed-with-fever-without-source-spirit-study-sub-analysis/)
- [ABSTRACT: The Performance Of The BV Score For Differentiating Between Bacterial And Viral Infection Is Robust To Methodological Alternatives In Building The Reference Standard](https://memed-staging.freshy.dev/learning_center/abstract-the-performance-of-the-bv-score-for-differentiating-between-bacterial-and-viral-infection-is-robust-to-methodological-alternatives-in-building-the-reference-standard/)
- [ABSTRACT: A Host‐protein Test Based On TRAIL, IP‐10 and Differentiates Between Adenoviral And Bacterial‐Adenoviral Co‐infections In Children With Positive PCR‐adenovirus Detection](https://memed-staging.freshy.dev/learning_center/abstract-a-host‐protein-test-based-on-trail-ip‐10-and-differentiates-between-adenoviral-and-bacterial‐adenoviral-co‐infections-in-children-with-positive-pcr‐a/)
- [ABSTRACT: Host-protein Score (Integrating TRAIL, IP-10, CRP) Distinguishes Between Viral And Viral-bacterial Coinfection In Adult Patients Testing Positive For Viral Detection](https://memed-staging.freshy.dev/learning_center/abstract-host-protein-score-integrating-trail-ip-10-crp-distinguishes-between-viral-and-viral-bacterial-coinfection-in-adult-patients-testing-positive-for-viral-detection/)
- [ABSTRACT: Host-Protein Score (integrating TRAIL, IP-10, CRP) Distinguishes Between Bacterial And Viral Infection In Suspected Sepsis Patients](https://memed-staging.freshy.dev/learning_center/abstract-host-protein-score-integrating-trail-ip-10-crp-distinguishes-between-bacterial-and-viral-infection-in-suspected-sepsis-patients/)
- [ABSTRACT: A TRAIL, IP-10, CRP Host-protein Score Distinguishes Viral From Viral-bacterial Co-infections In Adult Patients Testing Positive For Viral Detection](https://memed-staging.freshy.dev/learning_center/abstract-a-trail-ip-10-crp-host-protein-score-distinguishes-viral-from-viral-bacterial-co-infections-in-adult-patients-testing-positive-for-viral-detection/)
- [ABSTRACT: Real-world Use Of A Novel Host-response Test To Aid Physicians In Distinguishing Between Bacterial And Viral Infections At Outpatient Urgent Care Centers](https://memed-staging.freshy.dev/learning_center/abstract-real-world-use-of-a-novel-host-response-test-to-aid-physicians-in-distinguishing-between-bacterial-and-viral-infections-at-outpatient-urgent-care-centers/)
- [ABSTRACT: BV Score (based on TRAIL, IP-10 and CRP) Accurately Distinguishes Between Bacterial and Viral Infection in Febrile Children: A Multi-Cohort Analysis](https://memed-staging.freshy.dev/learning_center/abstract-bv-score-based-on-trail-ip-10-and-crp-accurately-distinguishes-between-bacterial-and-viral-infection-in-febrile-children-a-multi-cohort-analysis/)
- [PODCAST: Immune Response Can Guide COVID-19 Treatment](https://memed-staging.freshy.dev/learning_center/podcast-immune-response-can-guide-covid-19-treatment/)
- [PODCAST: BioBoss #26 – Eran Eden: Co-Founder and CEO of MeMed](https://memed-staging.freshy.dev/learning_center/podcast-bioboss-26-eran-eden-co-founder-and-ceo-of-memed/)
- [PODCAST: Is Your Kid’s Infection Bacterial or Viral? Eran Eden’s MeMed Can Tell](https://memed-staging.freshy.dev/learning_center/podcast-is-your-kids-infection-bacterial-or-viral-eran-edens-memed-can-tell/)
- [PUBLICATION: Validation of a Novel Assay to Distinguish Bacterial and Viral Infections](https://memed-staging.freshy.dev/learning_center/publication-validation-of-a-novel-assay-to-distinguish-bacterial-and-viral-infections/)

## Google Ads

- [AWARENESS Pop Up](https://memed-staging.freshy.dev/ad/awareness-pop-up/): MeMed BV Now the only reason to treat a bacterial infection is because there actually is one! In 15 minutes from a small sample, the FDA-cleared MeMed BV® computationally integrates the levels of three host immune proteins into a simple score indicating the likelihood of a bacterial immune response or co-infection versus a likely viral
- [UTILIZATION Pop Up](https://memed-staging.freshy.dev/ad/utilization-pop-up/): Now the only reason to treat a bacterial infection is because there actually is one! In 15 minutes from a small sample, the FDA-cleared MeMed BV® computationally integrates the levels of three host immune proteins into a simple score indicating the likelihood of a bacterial immune response or co-infection versus a likely viral immune response.

## Divi Bars

- [CTA](https://memed-staging.freshy.dev/divi_bars/cta/): Your Success Starts Here! Dive into the Adoption Guide and discover key insights to kickstart a successful MeMed BV program in your hospital!

## Events

- [Association for Diagnostics & Laboratory Medicine](https://memed-staging.freshy.dev/events/american-association-for-clinical-chemistry/)
- [Urgent Care Association Convention](https://memed-staging.freshy.dev/events/society-for-academic-emergency-medicine/)
- [American Academy of Emergency Medicine Scientific Assembly](https://memed-staging.freshy.dev/events/american-academy-of-emergency-medicine-scientific-assembly/)
- [European Society of Clinical Microbiology and Infectious Diseases](https://memed-staging.freshy.dev/events/eccmid/)
- [MEDICA 2023](https://memed-staging.freshy.dev/events/medica-2023/): Booth: 16J24 | Hall 16 Düsseldorf, Germany https://www.medica.de/
- [European Congress of Clinical Microbiology & Infectious Diseases](https://memed-staging.freshy.dev/events/european-congress-of-clinical-microbiology-infectious-diseases/)
- [American College of Emergency Physicians](https://memed-staging.freshy.dev/events/american-college-of-emergency-physicians/)

## Video Categories

- [COVID-19 Severity](https://memed-staging.freshy.dev/video-category/covid-19-severity/)

## Learning Center Categories

- [Publications](https://memed-staging.freshy.dev/learning_center_category/publications/)
- [Podcasts](https://memed-staging.freshy.dev/learning_center_category/podcasts/)
- [Presentations & Abstracts](https://memed-staging.freshy.dev/learning_center_category/presentations-abstracts/)
- [Webinars](https://memed-staging.freshy.dev/learning_center_category/webinars/)
- [Videos](https://memed-staging.freshy.dev/learning_center_category/videos/)